<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101573691</journal-id>
<journal-id journal-id-type="pubmed-jr-id">39703</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32294447</article-id>
<article-id pub-id-type="pmc">7473600</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2020.03.059</article-id>
<article-id pub-id-type="manuscript">NIHMS1622004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enhancing WNT Signaling Restores Cortical Neuronal Spine Maturation
and Synaptogenesis in <italic>Tbr1</italic> Mutants</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Darbandi</surname>
<given-names>Siavash Fazel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwartz</surname>
<given-names>Sarah E. Robinson</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pai</surname>
<given-names>Emily Ling-Lin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Everitt</surname>
<given-names>Amanda</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turner</surname>
<given-names>Marc L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheyette</surname>
<given-names>Benjamin N.R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willsey</surname>
<given-names>A. Jeremy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>State</surname>
<given-names>Matthew W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sohal</surname>
<given-names>Vikaas S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>John L.R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry and UCSF Weill Institute for
Neurosciences, University of California, San Francisco, San Francisco, CA 94143,
USA</aff>
<aff id="A2"><label>2</label>Institute for Neurodegenerative Diseases, UCSF Weill
Institute for Neurosciences, University of California, San Francisco, San Francisco,
CA 94143, USA</aff>
<aff id="A3"><label>3</label>Kavli Institute for Fundamental Neuroscience and
Sloan-Swartz Center for Theoretical Neurobiology, University of California, San
Francisco, San Francisco, CA 94143, USA</aff>
<aff id="A4"><label>4</label>Quantitative Biosciences Institute (QBI), University of
California, San Francisco, San Francisco, CA 94143, USA</aff>
<aff id="A5"><label>5</label>Senior author</aff>
<aff id="A6"><label>6</label>Lead Contact</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence:
<email>john.rubenstein@ucsf.edu</email></corresp>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">Conceptualization, S.F.D., V.S.S., and J.L.R.R.; Methodology, S.F.D.,
S.E.R.S., A.E., E.L.-L.P., M.L.T., A.J.W., B.N.R.C., V.S.S., and J.L.R.R.;
Investigation, S.F.D., S.E.R.S., A.E., M.L.T., and A.J.W.;
Writing–Original Draft, S.F.D., S.E.R.S., A.E., and J.L.R.R.;
Writing–Review &amp; Editing, S.F.D., V.S.S., A.J.W., M.W.S., and
J.L.R.R.; Funding Acquisition, A.J.W., M.W.S., V.S.S., and J.L.R.R.;
Supervision, M.W.S. and J.L.R.R.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<day>14</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>31</volume>
<issue>2</issue>
<fpage>107495</fpage>
<lpage>107495</lpage>
<!--elocation-id from pubmed: 10.1016/j.celrep.2020.03.059-->
<permissions>
<license license-type="open-access">
<license-p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P3"><italic>Tbr1</italic> is a high-confidence autism spectrum disorder (ASD)
gene encoding a transcription factor with distinct pre- and postnatal functions.
Postnatally, <italic>Tbr1</italic> conditional knockout (CKO) mutants and
constitutive heterozygotes have immature dendritic spines and reduced synaptic
density. <italic>Tbr1</italic> regulates expression of several genes that
underlie synaptic defects, including a kinesin (<italic>Kif1a</italic>) and a
WNT-signaling ligand (<italic>Wnt7b</italic>). Furthermore,
<italic>Tbr1</italic> mutant corticothalamic neurons have reduced thalamic
axonal arborization. LiCl and a GSK3β inhibitor, two WNT-signaling
agonists, robustly rescue the dendritic spines and the synaptic and axonal
defects, suggesting that this could have relevance for therapeutic approaches in
some forms of ASD.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract</title>
<p id="P4">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1622004-f0001.jpg"></graphic>
</p>
</abstract>
<abstract abstract-type="summary" id="ABS3">
<title>In Brief</title>
<p id="P5">Fazel Darbandi et al. demonstrate that TBR1 directly regulates
transcriptional circuits in cortical layers 5 and 6, which promote dendritic
spine and synaptic density. Enhancing WNT signaling rescues dendritic spine
maturation and synaptogenesis defects in <italic>Tbr1</italic> mutants. These
results provide insights into mechanisms that underlie ASD pathophysiology.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1">
<title>INTRODUCTION</title>
<p id="P6">Autism spectrum disorders (ASDs) are defined by deficits in social
interaction and abnormalities in language development and repetitive behavior.
Considerable genetic and phenotypic heterogeneity has complicated efforts to
understand the underlying biology of ASD. However, recent progress in the genomics
of ASD has revealed more than 65 high-confidence ASD (hcASD) risk genes (<xref ref-type="bibr" rid="R40">Sanders et al., 2015</xref>). Systems analyses suggest
that expression of ASD risk genes have important functions in mid-fetal deep-layer
cortical excitatory neurons and that disruption may contribute to ASD
pathophysiology (<xref ref-type="bibr" rid="R48">Willsey et al., 2013</xref>). Among
these ASD genes, analysis of the <italic>Tbr1</italic> transcription factor (TF) is
attractive, as it opens the possibility of defining a transcriptional pathway that
includes other ASD genes.</p>
<p id="P7"><italic>Tbr1</italic> has a central role in the development of mouse
early-born excitatory cortical neurons. <italic>Tbr1</italic> expression, which
begins in newborn neurons, dictates layer 6 identity (<xref ref-type="bibr" rid="R4">Bedogni et al., 2010</xref>; <xref ref-type="bibr" rid="R7">Bulfone et al.,
1998</xref>; <xref ref-type="bibr" rid="R25">Hevner et al., 2001</xref>, <xref ref-type="bibr" rid="R26">2003</xref>; <xref ref-type="bibr" rid="R33">McKenna
et al., 2011</xref>). Using <italic>Tbr1<sup>layer6</sup></italic> conditional
knockouts (CKOs), we recently demonstrated that neonatal <italic>Tbr1</italic>
function in layer 6 is required for maintaining corticothalamic identity and
synaptogenesis (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al.,
2018</xref>).</p>
<p id="P8">Here, we delved deeper into <italic>Tbr1</italic>’s function in
synaptogenesis in several ways. First, we identified convergent synaptic pheno-types
in <italic>Tbr1<sup>layer5</sup></italic> and <italic>Tbr1<sup>layer6</sup></italic>
CKOs and <italic>Tbr1<sup>constitutive</sup></italic>
(<italic>Tbr1</italic><sup>+/−</sup>) mutants, including a defect in the
formation of mature dendritic spines. Next, we used single-cell RNA sequencing
(scRNA-seq) of <italic>Tbr1<sup>layer5</sup></italic> mutant medial prefrontal
cortex (mPFC) neurons and identified <italic>Tbr1</italic>-regulated genes that
impact synapse formation in layer 5, including a kinesin motor protein
(<italic>Kif1a</italic>) and genes in the WNT-signaling pathway
(<italic>Gsk3β</italic>, <italic>Ctnnb1</italic>, and
<italic>Wnt7b</italic>). We also identified a number of
<italic>Tbr1</italic>-regulated ASD genes in the layer 5 neurons of the mPFC,
including <italic>Ank2</italic>, <italic>Ap2s1</italic>, <italic>Ctnnb1</italic>,
<italic>Dpysl2</italic>, <italic>Map1a</italic>, <italic>Rorb</italic>,
<italic>Smarcc2</italic>, and <italic>Gsk3β</italic>. Finally, we found
that LiCl, a drug approved by the US Food and Drug Administration, and a
GSK3β inhibitor (SB216763; Sigma-Aldrich) that promotes WNT signaling rescue
the spine and synaptic defects in adult <italic>Tbr1<sup>layer5</sup></italic>,
<italic>Tbr1<sup>layer6</sup></italic>, and
<italic>Tbr1<sup>constitutive</sup></italic>
(<italic>Tbr1</italic><sup>+/−</sup>) mutants. Lastly,
<italic>Tbr1<sup>layer5</sup></italic> mutants exhibit decreased social
interactions with young mice, a phenotype that is rescued with LiCl treatment. The
LiCl results suggest an important and novel biological mechanism underlying ASD that
may have implications for the treatment of patients with <italic>TBR1</italic>
mutations and, potentially, other individuals with ASD or related neurodevelopmental
disorders.</p>
</sec>
<sec id="S2">
<title>RESULTS</title>
<sec id="S3">
<title><italic>Tbr1</italic> Regulates Genes Involved in Cytoskeletal Dynamics and
Synaptogenesis in Layer 5 Pyramidal Neurons of Neonatal mPFC</title>
<p id="P9">In the frontal and motor cortex, <italic>Tbr1</italic> is expressed in
most excitatory neurons in layers 5 and 6, whereas layer 5 expression in other
cortical regions is limited to a minority of neurons (<xref ref-type="bibr" rid="R6">Bulfone et al., 1995</xref>). Here, using a floxed allele,
we selectively eliminated <italic>Tbr1</italic> in cortical layer 5 pyramidal
neurons around postnatal day (P)0 using <italic>Rbp4-cre</italic> ~8 days
after <italic>Tbr1</italic> expression begins. We refer to these mice as
<italic>Tbr1<sup>layer5</sup></italic> CKOs.</p>
<p id="P10">We focused on <italic>Tbr1</italic> function in the developing
prefrontal cortex (PFC), a region that is implicated in ASD (<xref ref-type="bibr" rid="R48">Willsey et al., 2013</xref>). To overcome the limitations
caused by cellular heterogeneity of batch RNA sequencing (RNA-seq)
(<italic>Tbr1</italic> is expressed in ~60% of layer 5 pyramidal
neurons at P5 and ~85% at P21; <xref ref-type="supplementary-material" rid="SD5">Figures S1A</xref> and <xref ref-type="supplementary-material" rid="SD5">S1B</xref>), we generated scRNA-seq data
from fluorescence-activated cell sorting (FACS) of layer 5 neurons isolated from
P5 mPFC (<xref ref-type="fig" rid="F1">Figure 1</xref>). We studied the
transcriptomic changes from
<italic>Tbr1</italic><sup><italic>wild-type</italic></sup>,
<italic>Tbr1<sup>layer5</sup></italic> heterozygous and homozygous CKO
cells using the 10X Genomics platform (GenBank GEO: <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE146298">GSE146298</ext-link>).</p>
<p id="P11">To identify genotype-dependent gene expression changes, we used a
t-distributed stochastic neighbor embedding (t-SNE) dimensionality reduction
followed by differential expression (DEX) analysis to identify neuronal cells
(<xref ref-type="fig" rid="F1">Figures 1A</xref> and <xref ref-type="supplementary-material" rid="SD5">S2</xref>). We captured 11,070 cells and
7,174 genes from <italic>Tbr1<sup>wild-type</sup></italic> (n = 1,778 cells),
<italic>Tbr1<sup>layer5</sup></italic> heterozygous (n = 5,357 cells),
and <italic>Tbr1<sup>layer5</sup></italic> homozygous (n = 3,935 cells) mutant
mPFCs that were used for downstream analysis (<xref ref-type="supplementary-material" rid="SD5">Figure S2</xref>). We excluded 873 cells
classified as atypical neuronal cells, with lower expression levels of
<italic>Neurod6</italic> and <italic>Nrgn</italic> (two excitatory neuronal
markers; <xref ref-type="supplementary-material" rid="SD5">Figures S3A</xref>
and <xref ref-type="supplementary-material" rid="SD5">S3D</xref>) and high
levels of housekeeping genes, from DEX analyses (gray cells in <xref ref-type="fig" rid="F1">Figure 1A</xref>). The t-SNE plot demonstrated clear
separation between <italic>Tbr1<sup>wid-type</sup></italic> and
<italic>Tbr1<sup>layer5</sup></italic> CKOs (<xref ref-type="fig" rid="F1">Figure 1A</xref>). DEX analysis identified 470 DEX genes when
comparing <italic>Tbr1<sup>layer5</sup></italic> homozygous mutants to
<italic>Tbr1</italic><sup><italic>wild-type</italic></sup> (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>) and 320 DEX genes when
comparing <italic>Tbr1ayer5</italic> heterozygous mutants to
<italic>Tbr1<sup>wild-type</sup></italic> (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>), 218 of which occur in
both comparisons (false discovery rate [FDR] ≨ 0.05) (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="supplementary-material" rid="SD3">Table S3</xref>). Feature plots showing
the expression of layer 5 markers in our scRNA-seq cell population are shown
(<xref ref-type="supplementary-material" rid="SD5">Figure S3i</xref>). Gene
Ontology (GO) analysis of DEX genes identified terms including
“axon,” “synapse,” “dendrite,”
“cell body,” and “neurogenesis” (<xref ref-type="fig" rid="F1">Figure 1B</xref>; <xref ref-type="supplementary-material" rid="SD4">Table S4</xref>).</p>
<p id="P12">To determine whether the changes in gene expression in
<italic>Tbr1<sup>layer5</sup></italic> CKOs are due to direct regulation
by TBR1, we used data from TBR1 chromatin immunoprecipitation (ChIP-seq) from P2
wild-type (WT) cortex (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al.,
2018</xref>). TBR1 binds to the promoters and distal regions of layer 5 DEX
genes (within 100 kb) (<xref ref-type="supplementary-material" rid="SD5">Figure
S1C</xref>). This suggests that TBR1 may be involved in controlling the
expression by activating or repressing the target genes.</p>
<p id="P13">We used <italic>in situ</italic> hybridization (ISH) to validate the
expression of several DEX genes (<xref ref-type="supplementary-material" rid="SD5">Table S5</xref>). Our scRNA-seq analysis
in conjunction with ISH aided in discovering <italic>Mgst3</italic>, as a new
layer 5 marker of prefrontal cortex (<xref ref-type="supplementary-material" rid="SD5">Figure S1D</xref>). To provide a
histological context, we defined laminar boundaries in the prefrontal cortex at
P3 using the following probes: <italic>Cux2</italic> (layers 2 and 3),
<italic>Rorb</italic> (layer 4), <italic>Etv1</italic> (layer 5),
<italic>Tbr1</italic> (layers 2–3, 5, 6, and 6b),
<italic>Nr4a2</italic> (subplate; <xref ref-type="fig" rid="F2">Figure
2i</xref>). Cortical layers 2–4 appear as a single layer at this
stage (<xref ref-type="fig" rid="F2">Figures 2A</xref>–<xref ref-type="fig" rid="F2">2F</xref>). Expression of <italic>Calm2</italic>,
<italic>Kif1a</italic>, <italic>Mgst3</italic>, and <italic>Wnt7b</italic>
was altered as suggested by the scRNA-seq analysis (<xref ref-type="fig" rid="F2">Figure 2ii</xref>; <xref ref-type="supplementary-material" rid="SD5">Figure S3ii</xref>). Thus, neonatal
<italic>Tbr1</italic> expression in layer 5 pyramidal neurons directly
regulates the expression of genes involved in cytoskeletal dynamics and synapse
development.</p>
</sec>
<sec id="S4">
<title>Excitatory and Inhibitory Synapses Are Reduced in
<italic>Tbr1<sup>layer5</sup></italic> Mutants</title>
<p id="P14">We assessed excitatory synapse numbers on apical dendrites of layer 5
neurons (within layer 2-3) in the mPFC by analyzing VGLUT1<sup>+</sup>
presynaptic terminals that are apposed to PSD95<sup>+</sup> postsynaptic zones
at P56 (<xref ref-type="fig" rid="F3">Figure 3A′</xref>) and P21 (<xref ref-type="supplementary-material" rid="SD5">Figures S4D</xref>-<xref ref-type="supplementary-material" rid="SD5">S4F</xref>) using
immunofluorescence (IF) and confocal microscopy. Inhibitory synaptic density was
assessed by counting the overlapping VGAT<sup>+</sup> presynaptic inhibitory
terminals and Gephyrin<sup>+</sup> dendritic postsynaptic zones on the apical
dendrites of layer 5 pyramidal neurons (n = 30 dendrites) at P56 (<xref ref-type="fig" rid="F3">Figure 3D′</xref>) and P21 (<xref ref-type="supplementary-material" rid="SD5">Figures S4J</xref>-<xref ref-type="supplementary-material" rid="SD5">S4L</xref>). Excitatory and inhibitory
synapses were decreased 34% and 42% in <italic>Tbr1<sup>layer5</sup></italic>
heterozygous and 70% and 73% in <italic>Tbr1<sup>layer5</sup></italic>
homozygous mutants at P56, respectively (<xref ref-type="fig" rid="F3">Figures
3A</xref> and <xref ref-type="fig" rid="F3">3D</xref>). A similar synaptic
deficit was also present at P21 (<xref ref-type="supplementary-material" rid="SD5">Figures S4G</xref> and <xref ref-type="supplementary-material" rid="SD5">S4M</xref>).</p>
<p id="P15">To assess the physiological consequences of the decrease in excitatory
and inhibitory synaptic densities, we measured spontaneous excitatory and
inhibitory post-synaptic currents (sEPSCs and sIPSCs, respectively) using
whole-cell patch clamp on the tdTomato<sup>+</sup> layer 5 pyramidal cells in
mPFC brain slices at P56 and P21 (<xref ref-type="fig" rid="F3">Figures
3B′</xref> and <xref ref-type="fig" rid="F3">3E′</xref>; <xref ref-type="supplementary-material" rid="SD5">Figures S4H</xref> and <xref ref-type="supplementary-material" rid="SD5">S4N</xref>). The sEPSC frequency
was reduced 25% in <italic>Tbr1<sup>layer5</sup></italic> heterozygous and 75%
in <italic>Tbr1<sup>layer5</sup></italic> homozygous mutants; furthermore, the
frequency of sIPSCs was reduced 30% in <italic>Tbr1<sup>layer5</sup></italic>
heterozygous and 50% in <italic>Tbr1<sup>layer5</sup></italic> homozygous
mutants as compared to cells from <italic>Tbr1<sup>wild-type</sup></italic> mice
at P56 (<xref ref-type="fig" rid="F3">Figures 3B</xref> and <xref ref-type="fig" rid="F3">3E</xref>). Similar decreases were also present at P21 (<xref ref-type="supplementary-material" rid="SD5">Figures S4I</xref> and <xref ref-type="supplementary-material" rid="SD5">S4O</xref>). We did not observe
changes in the amplitude of sEPSCs and sIPSCs at P21 and P56 (data not
shown).</p>
<p id="P16">Since most <italic>de novo</italic> ASD-risk genes are heterozygous,
loss-of-function, rare variants, we explored the consequence of constitutive
<italic>Tbr1</italic> haploinsufficiency on synapse numbers of layer 5 and
layer 6 pyramidal neurons using <italic>Tbr1</italic><sup>+/−</sup> mice
(<xref ref-type="bibr" rid="R6">Bulfone et al., 1995</xref>). We counted
excitatory and inhibitory synapse numbers in the mPFC of
<italic>Tbr1</italic><sup>+/−</sup>∷<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
(layer 5 neurons) and the somatosensory cortex (SSCx) of
<italic>Tbr1</italic><sup>+/−</sup>∷<italic>Ntsr1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
(layer 6 neurons) at P56 (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="fig" rid="F2">i2</xref> and <xref ref-type="fig" rid="F2">ii2</xref>). Layer 5 excitatory and inhibitory synapse numbers were reduced
~40% and ~35% in the mPFC of
<italic>Tbr1</italic><sup>+/−</sup>∷<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
at P56 (<xref ref-type="fig" rid="F3">Figures 3C</xref> and <xref ref-type="fig" rid="F3">3F</xref>). Layer 6 neurons in the SSCx of
<italic>Tbr1</italic><sup>+/−</sup>∷<italic>Ntsr1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
showed ~37% and ~39% decreases in excitatory and inhibitory
synaptic densities, respectively (<xref ref-type="fig" rid="F3">Figures
3C</xref> and <xref ref-type="fig" rid="F3">3F</xref>). Thus,
<italic>Tbr1</italic> haploinsufficiency results in reduced synaptic density
on the excitatory neurons of cortical layers 5 and 6.</p>
</sec>
<sec id="S5">
<title><italic>Kif1a</italic> Expression Restores Normal Synapse Numbers in
<italic>Tbr1<sup>layer5</sup></italic> Mutant Neurons <italic>In
Vitro</italic></title>
<p id="P17">We sought to identify molecular mechanisms underlying the decrease in
the excitatory and inhibitory synaptic densities in
<italic>Tbr1<sup>layer5</sup></italic> CKO neurons using the results
from the scRNA-seq analysis (<xref ref-type="fig" rid="F1">Figure 1</xref>). We
assessed a subset of DEX genes that control synapse biology, including
<italic>Kif1a</italic> (<xref ref-type="bibr" rid="R30">Li et al.,
2016</xref>), <italic>Mef2c</italic> (<xref ref-type="bibr" rid="R3">Barbosa
et al., 2008</xref>), <italic>Rac3</italic>, and <italic>Syt4</italic>
(<xref ref-type="bibr" rid="R2">Barber et al., 2009</xref>). We examined
whether <italic>Kif1a</italic>, <italic>Mef2c</italic>, <italic>Rac3</italic>,
and <italic>Syt4</italic> could rescue synapse density by expressing them in P0
primary cortical cultures derived from <italic>Tbr1<sup>wild-type</sup></italic>
and <italic>Tbr1<sup>layer5</sup></italic> mutant neurons (n = 3 biological
replicates).</p>
<p id="P18">After 14 days <italic>in vitro</italic>, we analyzed the number of
excitatory (VGLUT<sup>+</sup> presynaptic and PSD95<sup>+</sup> postsynaptic)
and inhibitory (VGAT<sup>+</sup> presynaptic and Gephyrin<sup>+</sup>
postsynaptic) terminals of <italic>Tbr1<sup>wlid-type</sup></italic> and
<italic>Tbr1<sup>layer5</sup></italic> homozygous mutant neurons (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="fig" rid="F3">iii</xref>). The reduced excitatory and inhibitory synaptic densities onto
<italic>Tbr1<sup>layer5</sup></italic> CKO neurons were recapitulated
<italic>in vitro</italic> (<xref ref-type="fig" rid="F3">Figures 3G</xref>,
<xref ref-type="fig" rid="F3">3G′</xref>, <xref ref-type="fig" rid="F3">3H</xref>, and <xref ref-type="fig" rid="F3">3H′</xref>). Only <italic>Kif1a</italic> rescued the reduction in
both excitatory (<xref ref-type="fig" rid="F3">Figures 3G</xref> and <xref ref-type="fig" rid="F3">3G′</xref>) and inhibitory (<xref ref-type="fig" rid="F3">Figures 3H</xref> and <xref ref-type="fig" rid="F3">3H′</xref>) synapse numbers. <italic>Kif1a</italic>, a kinesin motor
protein, is implicated in the transport of vesicles for synapse development
(<xref ref-type="bibr" rid="R22">Guedes-Dias et al., 2019</xref>) and thus
may contribute to <italic>Tbr1</italic>’s function in promoting synapse
formation.</p>
</sec>
<sec id="S6">
<title><italic>Tbr1<sup>layer5</sup></italic> CKOs Have Increased
Hyperpolarization-Activated Cation Currents (I<sub>h</sub>s)</title>
<p id="P19">We next examined the intrinsic properties of layer 5 neurons in
<italic>Tbr1<sup>layer5</sup></italic> WT and CKOs using whole-cell
patch clamp to measure intrinsic physiological properties of
<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup>+</sup>
neurons of layer 5 in the mPFC (<xref ref-type="supplementary-material" rid="SD5">Figure S5A</xref>). Resting membrane
potential and input resistance were not different between
<italic>Tbr1<sup>wild-type</sup></italic>,
<italic>Tbr1<sup>layer5</sup></italic> heterozygotes and homozygotes at P56
(<xref ref-type="supplementary-material" rid="SD5">Figures S5B</xref> and
<xref ref-type="supplementary-material" rid="SD5">S5C</xref>).</p>
<p id="P20">A prominent feature of many layer 5 pyramidal neurons is the presence of
an I<sub>h</sub> (or h-current) mediated by hyperpolarization-activated cyclic
nucleotide–gated HCN channels (<xref ref-type="bibr" rid="R43">Shepherd,
2013</xref>). I<sub>h</sub> causes a characteristic “sag” and
“rebound” in current clamp recordings of responses to steps of
hyperpolarizing current. We examined responses to a −200-pA step and
found that mPFC layer 5 pyramidal neurons from P56
<italic>Tbr1<sup>layer5</sup></italic> heterozygotes and homozygotes
exhibited a significantly increased “sag and rebound” compared to
<italic>Tbr1<sup>wild-type</sup></italic> controls, suggesting increased
I<sub>h</sub>, while other intrinsic electrophysiological properties were
largely unaltered (<xref ref-type="supplementary-material" rid="SD5">Figure
S5D</xref>).</p>
<p id="P21">In deep-layer neocortical pyramidal neurons, the presence of
I<sub>h</sub> shifts the resonant frequency toward higher frequencies (<xref ref-type="bibr" rid="R15">Dembrow et al., 2010</xref>). Therefore, to
further characterize potential increases in I<sub>h</sub> in
<italic>Tbr1<sup>layer5</sup></italic> CKOs, we estimated the resonant
frequency by injecting constant current to hold
<italic>Rbp4-cre</italic><sup>+</sup> neurons in current clamp near
−70 mV and then introduced a sinusoidal current stimulus with constant
amplitude (100 pA, peak to peak) and a frequency that increased linearly from 0
to 20 Hz over 20 s (<xref ref-type="supplementary-material" rid="SD5">Figure
S5E</xref>). <italic>Tbr1<sup>layer5</sup></italic> heterozygous and
homozygous CKOs exhibited an increase in their resonant frequency compared to
<italic>Tbr1<sup>wild-type</sup></italic> controls at P56 (<xref ref-type="supplementary-material" rid="SD5">Figure S5G</xref>).</p>
<p id="P22">Lastly, we blocked I<sub>h</sub> by bath applying the specific HCN
channel antagonist ZD7288 (25 μM; <xref ref-type="supplementary-material" rid="SD5">Figure S5F</xref>). The resonant frequency
was reduced by over 50% in the <italic>Tbr1<sup>layer5</sup></italic>
heterozygous and <italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs (<xref ref-type="supplementary-material" rid="SD5">Figure S5G</xref>). Thus, both
<italic>Tbr1<sup>layer5</sup></italic> heterozygotes and homozygotes
have an increased I<sub>h</sub> in layer 5 pyramidal neurons of the mPFC.</p>
</sec>
<sec id="S7">
<title><italic>Tbr1</italic> Mutants Have Reduced Mature Dendritic Spine
Density</title>
<p id="P23">The synaptic deficits described earlier prompted us to investigate the
state of dendritic spines in <italic>Tbr1<sup>layer5</sup></italic> CKOs,
<italic>Tbr1<sup>layer6</sup></italic> CKOs (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>), and
<italic>Tbr1</italic><sup>+/−</sup> mutants. We visualized
tdTomato<sup>+</sup> spines using Airyscan confocal microscopy to capture
120×-magnification z stack images (using 2× optical zoom) from the
dendrites of layer 6 and layer 5 neurons of WT,
<italic>Tbr1<sup>layer5</sup></italic> (<xref ref-type="fig" rid="F4">Figure
4</xref>), <italic>Tbr1<sup>layer6</sup></italic>, and
<italic>Tbr1</italic><sup>+/−</sup> mutant neurons at P5, P21, and
P60 (<xref ref-type="supplementary-material" rid="SD5">Figure S6</xref>). We
used Imaris software (v.9.2.1) to analyze dendritic spine morphology, density,
and distribution.</p>
<p id="P24">There were reductions in the density of mature dendritic spine density
in <italic>Tbr1</italic> heterozygotes and homozygotes in
<italic>Tbr1<sup>layer5</sup></italic> and
<italic>Tbr1<sup>layer6</sup></italic> CKOs (<xref ref-type="fig" rid="F4">Figures 4</xref> and <xref ref-type="supplementary-material" rid="SD5">S6</xref>). Additionally, <italic>Tbr1</italic><sup>+/−</sup>
mutants have reduced mature spine density on the dendrites of layer 5 and layer
6 pyramidal neurons (<xref ref-type="supplementary-material" rid="SD5">Figure
S6</xref>). Furthermore, <italic>Tbr1</italic> mutant neurons had an
increased filamentous spine density (<xref ref-type="supplementary-material" rid="SD5">Figure S6</xref>). Thus, this defect in
mature dendritic spine density may underlie the reduction in synapse numbers in
<italic>Tbr1</italic> mutants.</p>
</sec>
<sec id="S8">
<title>Restoring Reduced WNT Signaling in <italic>Tbr1</italic> CKOs Rescues
Synaptic Deficits</title>
<p id="P25">We demonstrated that <italic>Tbr1</italic> promotes synaptogenesis onto
layer 6 neurons in part via WNT signaling through <italic>Wnt7b</italic> (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>). WNT signaling
promotes dendrite maturation and synapse formation (<xref ref-type="bibr" rid="R11">Ciani and Salinas, 2005</xref>). Here, we found several
lines of evidence to further support the role of <italic>Tbr1</italic>-dependent
WNT signaling in synapse development. First, <italic>Wnt7b</italic> and
<italic>Ctnnb1</italic> expression was reduced in the mPFC of
<italic>Tbr1<sup>layer5</sup></italic> CKOs (<xref ref-type="fig" rid="F1">Figures 1</xref> and <xref ref-type="fig" rid="F2">2</xref>;
<xref ref-type="supplementary-material" rid="SD1">Tables S1</xref> and <xref ref-type="supplementary-material" rid="SD2">S2</xref>).
<italic>Ctnnb1</italic> encodes β-catenin, the critical intracellular
transducer of canonical WNT signaling (<xref ref-type="bibr" rid="R5">Budnik and
Salinas, 2011</xref>). Second, <italic>Tbr1<sup>layer5</sup></italic> CKOs
had increased <italic>Gsk3β</italic> RNA expression (<xref ref-type="fig" rid="F1">Figure 1</xref>); GSK3β negatively regulates WNT
signaling through increasing the destruction of β-catenin (<xref ref-type="bibr" rid="R46">van Noort et al., 2002</xref>).</p>
<p id="P26">Thus, we tested whether promoting WNT signaling could rescue dendritic
spine and synapse phenotypes. Among its several pharmacological effects, there
is evidence that LiCl, a WNT-signaling agonist, promotes synapse development
(<xref ref-type="bibr" rid="R16">Farooq et al., 2017</xref>; <xref ref-type="bibr" rid="R29">Lenox and Wang, 2003</xref>; <xref ref-type="bibr" rid="R32">Martin et al., 2018</xref>). Thus, we administered LiCl and a GSK3β
inhibitor (SB216763, Sigma-Aldrich) to <italic>Tbr1</italic> mutants.</p>
</sec>
<sec id="S9">
<title>LiCl Treatment of <italic>Tbr1</italic> Mutants Restores Dendritic Spine
Density and Synapse Development</title>
<p id="P27">As noted earlier, <italic>Tbr1</italic> mutants have a reduced density
of mature dendritic spines (<xref ref-type="fig" rid="F4">Figures 4</xref> and
<xref ref-type="supplementary-material" rid="SD5">S6</xref>). We tested
whether promoting WNT signaling by administering LiCl at P5 and P59 could rescue
the reduction in mature spine density and synaptogenesis in
<italic>Tbr1</italic> mutants. We gave a single intraperitoneal (i.p.)
injection of 400 mg/kg LiCl; control animals received a single i.p. injection of
4 mL/kg saline. Impressively, LiCl treatment rescued the density of mature
dendritic spines within 24 h in <italic>Tbr1</italic> mutants; LiCl did not have
a clear effect on the density of WT dendritic spines (<xref ref-type="fig" rid="F4">Figures 4</xref> and <xref ref-type="supplementary-material" rid="SD5">S6</xref>). These results, in combination
with the previously reported evidence that <italic>Wnt7b</italic> restores
synapse numbers on <italic>Tbr1<sup>layer6</sup></italic> mutant neurons (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>), led us to
test whether LiCl can rescue synapse numbers on adult <italic>Tbr1</italic>
mutant layer 5 and layer 6 neurons.</p>
<p id="P28">We administered LiCl to <italic>Tbr1<sup>layer5</sup></italic> WT and
homozygous CKOs (<xref ref-type="fig" rid="F5">Figures 5A</xref> and <xref ref-type="fig" rid="F5">5E</xref>), <italic>Tbr1<sup>layer6</sup></italic>
WT and homozygous CKOs (<xref ref-type="fig" rid="F5">Figures 5B</xref> and
<xref ref-type="fig" rid="F5">5F</xref>), and
<italic>Tbr1</italic><sup>+/−</sup> mutants (<xref ref-type="fig" rid="F5">Figure 5</xref>). Layer 5 and layer 6 projection neurons were
labeled with
<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
and
<italic>Ntsr1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>,
respectively. The control and LiCl-treated brains were harvested either 24 h or
4 weeks after injection at P60 (<xref ref-type="fig" rid="F5">Figures 5</xref>
and <xref ref-type="supplementary-material" rid="SD5">S7</xref>). Confocal
images of IF from the mPFC (layer 5) and SSCx (layer 6) showed a nearly complete
rescue of synaptic densities, 24 h and 4 weeks after treatment (<xref ref-type="fig" rid="F5">Figures 5</xref> and <xref ref-type="supplementary-material" rid="SD5">S7</xref>). LiCl treatment also rescued
synaptic densities in the mPFC (layer 5) and SSCx (layer 6) of the constitutive
<italic>Tbr1</italic><sup>+/−</sup> mutants (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<p id="P29">Thus, LiCl treatment of <italic>Tbr1<sup>layer5</sup></italic>,
<italic>Tbr1<sup>layer6</sup></italic>, and
<italic>Tbr1</italic><sup>+/−</sup> mutant mice at P60 rescues both
excitatory and inhibitory synaptic deficit in <italic>Tbr1</italic> mutant
neurons of cortical layers 5 and 6 (<xref ref-type="fig" rid="F5">Figures
5A</xref>-<xref ref-type="fig" rid="F5">5H</xref>). Here, we postulate that
<italic>Tbr1</italic> mutant neurons are in a “poised” state
but are not able to form synapses due to a defect in WNT signaling. Thus, we
provide <italic>in vivo</italic> evidence that augmenting WNT signaling via LiCl
treatment is sufficient to restore normal synapse numbers.</p>
</sec>
<sec id="S10">
<title>GSK3β Inhibitor Restores Defects in Dendritic Spine and Synaptic
Density of <italic>Tbr1</italic> Mutants</title>
<p id="P30">Promoting WNT signaling via LiCl treatment of <italic>Tbr1</italic>
mutants rescued the defects in mature spine and synaptic density (<xref ref-type="fig" rid="F5">Figures 5</xref> and <xref ref-type="supplementary-material" rid="SD5">S7</xref>). Lithium’s best
validated mechanisms of action are inhibitory effects on IMP and INPP1, central
phosphatases in the phosphoinositide pathway, and on GSK3β, the central
kinase in the Wnt/β-catenin and AKT pathways (<xref ref-type="bibr" rid="R29">Lenox and Wang, 2003</xref>). To ascertain whether WNT
signaling is the main mechanism underlying the defects in dendritic spine and
synaptic density of <italic>Tbr1</italic> mutants, we used a GSK3β
inhibitor (SB216763; Sigma-Aldrich).</p>
<p id="P31">A single i.p. injection of GSK3β inhibitor (10 mg/kg) was given
to <italic>Tbr1</italic> CKOs and WT at P59. Control animals received a single
i.p. injection of 4 mL/kg saline at P59. We studied the effects of these
treatments on <italic>Tbr1<sup>layer5</sup></italic> WT and homozygous CKOs
(<xref ref-type="supplementary-material" rid="SD5">Figure S8i</xref>) and on
<italic>Tbr1<sup>layer6</sup></italic> WT and homozygous CKOs (<xref ref-type="supplementary-material" rid="SD5">Figure S8ii</xref>). Layer 5 and
layer 6 projection neurons were labeled with
<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
and
<italic>Ntsr1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>,
respectively. The control and GSK3β-inhibitor-treated brains were
harvested after 24 h (<xref ref-type="supplementary-material" rid="SD5">Figure
S8</xref>). GSK3β-inhibitor treatment rescued the decrease in mature
spine density in <italic>Tbr1</italic> CKO mutants (<xref ref-type="supplementary-material" rid="SD5">Figures S8C</xref> and <xref ref-type="supplementary-material" rid="SD5">S8F</xref>). Furthermore, IF analysis of
excitatory and inhibitory synaptic densities from the
<italic>Tbr1<sup>layer5</sup></italic> CKO mPFC (layer 5; <xref ref-type="supplementary-material" rid="SD5">Figures S8A</xref> and <xref ref-type="supplementary-material" rid="SD5">S8B</xref>) and from the
<italic>Tbr1<sup>layer6</sup></italic> CKO SSCx (layer 6; <xref ref-type="supplementary-material" rid="SD5">Figures S8D</xref> and <xref ref-type="supplementary-material" rid="SD5">S8E</xref>) showed a nearly
complete rescue of synaptic density 24 h after treatment (<xref ref-type="supplementary-material" rid="SD5">Figure S8</xref>).</p>
<p id="P32">Thus, GSK3β inhibitor treatment of
<italic>Tbr1<sup>layer5</sup></italic> and
<italic>Tbr1<sup>layer6</sup></italic> CKO mice at P60 rescues dendritic
spine density as well as excitatory and inhibitory synaptic deficit in
<italic>Tbr1</italic> mutant neurons of cortical layers 5 and 6,
respectively (<xref ref-type="supplementary-material" rid="SD5">Figure
S8</xref>). This provides an additional line of evidence that augmenting WNT
signaling is a key mechanism in restoring mature dendritic spine and synaptic
density in <italic>Tbr1</italic> mutants.</p>
</sec>
<sec id="S11">
<title>LiCl and GSK3β Inhibitor Treatment at P60 Improves Corticothalamic
Axonal Arborization in <italic>Tbr1<sup>layar6</sup></italic> Mutant</title>
<p id="P33">Layer 6 corticothalamic neurons extend their axons to the thalamus where
they form synapses. Corticothalamic axons enter the thalamus in
<italic>Tbr1<sup>layerr6</sup></italic> CKOs; however, the
corticothalamic axonal arborization is reduced in the anteromedial thalamus of
<italic>Tbr1<sup>layer6</sup></italic> CKOs (white arrowheads in <xref ref-type="fig" rid="F5">Figure 5M</xref>) (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>). Treatment with either LiCl or
GSK3β inhibitor rescued this defect after 24 h (yellow arrowheads in
<xref ref-type="fig" rid="F5">Figures 5N</xref> and <xref ref-type="fig" rid="F5">5O</xref>) and 4 weeks
(yellow arrowheads in <xref ref-type="fig" rid="F5">Figure 5P</xref>).
Quantification of tdTomato pixel intensity in the anteromedial thalamus (boxed
region in <xref ref-type="fig" rid="F5">Figures 5I</xref> and <xref ref-type="fig" rid="F5">5M</xref>) showed a significant increase after treatment
(<xref ref-type="fig" rid="F5">Figure 5</xref>, <xref ref-type="fig" rid="F5">iv</xref>). We estimate that LiCl increased the
corticothalamic axonal arborization by ~250 μm in 24 h. Axon
growth rates in multiple regions of the nervous system and species have been
documented to range from 20 to 75 μm/h (equivalent to ~2,000
μm/24 h) (<xref ref-type="bibr" rid="R19">Goldberg, 2003</xref>; <xref ref-type="bibr" rid="R28">Lallemend et al., 2012</xref>). We postulate that
the rescue of the axonal arbors is through enhanced levels of WNT signaling as
result of the LiCl or GSK3β inhibitor treatment.</p>
</sec>
<sec id="S12">
<title>Evidence that WNT Signaling Promotes Synaptogenesis in <italic>Tbr1</italic>
CKOs through an Autocrine Mechanism</title>
<p id="P34">Previously, we demonstrated that restoring <italic>in vivo</italic>
<italic>Wnt7b</italic> expression in layer 6 pyramidal neurons of
<italic>Tbr1<sup>layer6</sup></italic> CKOs promoted synaptogenesis onto
layer 6 neurons (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al.,
2018</xref>). Here, we have verified this finding and included additional
controls (<xref ref-type="supplementary-material" rid="SD5">Figures S9A</xref>
and <xref ref-type="supplementary-material" rid="SD5">S9B</xref>).</p>
<p id="P35">Toward elucidating whether WNT7B functions through autocrine and/or
paracrine mechanisms, we used cortical transplantation of
<italic>Wnt7b</italic>-expressing cortical interneurons to study synaptogenesis
in <italic>Tbr1<sup>layer6</sup></italic> CKO and control (WT) mice. We
introduced medial ganglionic eminence (MGE)-derived cortical interneurons (MGE
donor cells from
<italic>Nkx2.1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
background) harboring either a <italic>Wnt7b</italic> expression construct
(<italic>pLenti-DlxI12b-Wnt7b-GFP</italic>) or a control vector
(<italic>pLenti-DlxI12b-GFP</italic>) into deep cortical layers of
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer6</sup></italic> CKOs at P1; we analyzed
excitatory synaptic density in cortex at P30. We quantified excitatory synapses
on apical dendrites of WT and <italic>Tbr1<sup>layer6</sup></italic> CKOs layer
6 neurons, adjacent to the MGE-transplanted cells
(tdTomato<sup>+</sup>-GFP<sup>+</sup>) within layer 5 (<xref ref-type="supplementary-material" rid="SD5">Figures S9C</xref>-<xref ref-type="supplementary-material" rid="SD5">S9F</xref>). We did not observe a rescue
of synapse numbers (<xref ref-type="supplementary-material" rid="SD5">Figure
S9E</xref>). Furthermore, we did not observe an increase of excitatory
synapses onto the soma of the transplanted <italic>Wnt7b</italic>-expressing
interneurons (<xref ref-type="supplementary-material" rid="SD5">Figure
S9F</xref>). Thus, this experiment provides evidence that WNT7B promotes
synaptogenesis in cortical excitatory neurons through a cell-autonomous
autocrine mechanism.</p>
</sec>
<sec id="S13">
<title><italic>Tbr1<sup>layer5</sup></italic> CKOs Exhibit Social Interaction
Defects that Are Rescued by LiCl Treatment</title>
<p id="P36">We studied motor function, anxiety, and social interaction of
<italic>Tbr1<sup>layer5</sup></italic> mutant mice between P56 and P80.
Motor defects were not detected based on speed in an open field or performance
on a rotarod (data not shown). To assay social behavior, we measured the time
the experimental mouse spent exploring a novel juvenile WT mouse of the same
sex. Subsequently, we measured the amount of time the subject mouse spent
exploring a novel object. <italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs
exhibited social interaction deficit with a juvenile mouse; we did not observe a
social deficit between <italic>Tbr1<sup>layer5</sup></italic> WT and
<italic>Tbr1<sup>layer5</sup></italic> heterozygous CKOs (data not
shown). Loss of <italic>Tbr1</italic> in layer 5 neurons did not affect the
amount of time <italic>Tbr1<sup>layer5</sup></italic> CKOs spent exploring a
novel object compared to the WT.</p>
<p id="P37">The improved synaptic density of <italic>Tbr1<sup>layer5</sup></italic>
CKOs due to LiCl treatment prompted us to assess the impact of LiCl treatment on
the social interaction of <italic>Tbr1<sup>layer5</sup></italic> CKOs. We
performed the novel object exploration and social interaction assays at P60
using <italic>Tbr1<sup>layer5</sup></italic> WT and CKOs that were treated with
a single i.p. injection of saline (control) and LiCl (experimental) 4 weeks
prior to the behavioral assays. LiCl treatment of
<italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs improved their social
interaction deficit with a juvenile mouse (<xref ref-type="fig" rid="F6">Figure
6A</xref>), while LiCl treatment did not affect a novel object assay (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Thus, LiCl rescues defects in
dendritic spines, synapse density, and the social behavior of
<italic>Tbr1<sup>layer5</sup></italic> CKOs.</p>
</sec>
</sec>
<sec id="S14">
<title>DISCUSSION</title>
<sec id="S15">
<title><italic>Tbr1</italic> Dosage in Layers 5 and 6 Is Essential for Promoting and
Maintaining Dendritic Spine and Synaptic Density</title>
<p id="P38"><italic>Tbr1</italic> is expressed in post-mitotic excitatory neurons in
the neocortex, hippocampus, entorhinal cortex, pallial amygdala, piriform
cortex, olfactory bulb, Cajal-Retzius cells, and subplate neurons (<xref ref-type="bibr" rid="R25">Hevner et al., 2001</xref>, <xref ref-type="bibr" rid="R26">2003</xref>). <italic>Tbr1</italic> is best known for its
expression and function in layer 6, where it is required to initiate and then
maintain layer 6 identity by repressing markers of layer 5 identity (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>; <xref ref-type="bibr" rid="R33">McKenna et al., 2011</xref>). There is also
prominent <italic>Tbr1</italic> expression in layer 5 of the rostral cortex,
where it is expressed in ~85% of pyramidal neurons (<xref ref-type="bibr" rid="R6">Bulfone et al., 1995</xref>).</p>
<p id="P39">Here, by deleting <italic>Tbr1</italic> late in gestation using a
layer-5-specific Cre (<italic>Rbp4-Cre</italic>), we have investigated the role
of <italic>Tbr1</italic> in mPFC development. scRNA-seq from FACS-purified layer
5 neurons of <italic>Tbr1wild-type</italic> and
<italic>Tbr1<sup>layer5</sup></italic> heterozygous and homozygous CKOs
demonstrated that <italic>Tbr1</italic> deletion in mPFC layer 5 alters the
expression of a subset of genes that control synaptogenesis, synaptic
maturation, and microtubule assembly (<xref ref-type="supplementary-material" rid="SD1">Tables S1</xref> and <xref ref-type="supplementary-material" rid="SD2">S2</xref>).</p>
<p id="P40">The core phenotypes of the <italic>Tbr1</italic> CKOs are: (1) reduction
in the density of mature dendritic spine density (<xref ref-type="fig" rid="F4">Figures 4</xref> and <xref ref-type="supplementary-material" rid="SD5">S6</xref>); (2) increased density of immature filamentous (thin) spines
(<xref ref-type="supplementary-material" rid="SD5">Figure S6</xref>); and
(3) reduced density of excitatory and inhibitory synapses (<xref ref-type="fig" rid="F3">Figures 3</xref> and <xref ref-type="supplementary-material" rid="SD5">S4</xref>). The dendritic spine defect is
apparent at the beginning of synaptogenesis (P5) and is maintained through
adolescence and into adulthood (<xref ref-type="fig" rid="F4">Figures 4</xref>
and <xref ref-type="supplementary-material" rid="SD5">S6</xref>). Notably, the
<italic>Tbr1</italic> CKOs neurons have an increased I<sub>h</sub>. There is
evidence that HCN channels, the mediator of Ih, localize to thin spines (<xref ref-type="bibr" rid="R36">Paspalas et al., 2013</xref>). Thus, we
hypothesize that the increased I<sub>h</sub> in <italic>Tbr1</italic> CKOs may
be attributed to the increased filamentous spine density in
<italic>Tbr1</italic> CKOs. Support for this notion comes from the
observation that layer 5 neurons have an ~2-fold increased density of
filamentous spines compared to that of layer 6 neurons (<xref ref-type="supplementary-material" rid="SD5">Figures S6E</xref> and <xref ref-type="supplementary-material" rid="SD5">S6F</xref>), which correlates with higher
I<sub>h</sub> in layer 5 neurons (<xref ref-type="bibr" rid="R43">Shepherd,
2013</xref>).</p>
<p id="P41">We postulate that the reduced mature spine density is central to the
reduction of excitatory synapses and synaptic activity observed in adolescent
(P21) and adult (P56) <italic>Tbr1<sup>layer5</sup></italic> CKOs. In addition,
<italic>Tbr1<sup>layer6</sup></italic> CKOs (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>), as well as
<italic>Tbr1</italic><sup>+/−</sup> constitutive mutants, show
defects in dendritic spines and synapses. The fact that we observed defects in
dendritic spine and synapse density in <italic>Tbr1</italic> heterozygous CKOs
and <italic>Tbr1</italic><sup>+/−</sup> constitutive mutants implies that
this phenotype could contribute to the behavioral phenotypes in neuropsychiatric
disorders such as ASD. This hypothesis is further strengthened by the dendritic
spine and synaptic phenotypes in the mPFC, a cortical region with critical
functions in cognitive and affective processing.</p>
</sec>
<sec id="S16">
<title>Molecular Mechanisms Downstream of <italic>Tbr1</italic> that Promote Synapse
Development</title>
<p id="P42">We have evidence that TBR1 controls synaptic development by promoting
spine maturation and synaptogenesis through several mechanisms.
<italic>Tbr1</italic> promotes WNT signaling (discussed more extensively
later), and TBR1 directly drives the expression of <italic>Cyp26b1</italic>,
<italic>Foxp2</italic>, <italic>Mef2c</italic>, and <italic>Wnt7b</italic>
in layer 6 (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>),
as well as <italic>Kif1a</italic> and <italic>Wnt7b</italic> in layer 5. We
integrated these findings into a molecular model (<xref ref-type="fig" rid="F7">Figure 7</xref>). The model also postulates how LiCl and GSK3β
inhibitor treatments, through promoting WNT signaling, rescues synaptic and
axonal phenotypes in <italic>Tbr1</italic> mutants (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<p id="P43"><italic>Tbr1</italic> promotes the expression of <italic>Foxp2</italic>
(a hcASD gene) and <italic>Mef2c</italic> transcription factors (TFs) in layer 6
(<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>).
<italic>Mef2c</italic> promotes the development of excitatory synapses
(<xref ref-type="bibr" rid="R23">Harrington et al., 2016</xref>). However,
restoring <italic>Mef2c</italic> expression in <italic>Tbr1</italic> mutant
neurons failed to rescue their synaptic deficit, suggesting that decreased
expression of this TF alone does not underlie the synaptic deficits in
<italic>Tbr1</italic> mutants.</p>
<p id="P44"><italic>Tbr1</italic> also promotes the expression of
<italic>Cyp26b1</italic>, a gene encoding a retinoic-acid (RA)-degrading
enzyme, in layer 6 pyramidal neurons. Restoring <italic>Cyp26b1</italic>
expression in primary cortical cultures from
<italic>Tbr1<sup>layer6</sup></italic> CKOs rescued synaptic deficit
<italic>in vitro</italic> (<xref ref-type="supplementary-material" rid="SD5">Figures S9E</xref> and <xref ref-type="supplementary-material" rid="SD5">S9F</xref>). RA acts via RARα in synapses to promote protein
synthesis (<xref ref-type="bibr" rid="R9">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="R8">Chen and Napoli, 2008</xref>). This suggests that
<italic>Tbr1</italic>’s control of RA levels, via
<italic>Cyp26b1</italic>, can impact synaptic development (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<p id="P45">While these three mechanisms appear to contribute to
<italic>Tbr1</italic>’s orchestration of synapse development, we
believe that <italic>Tbr1</italic>’s control of WNT signaling may be the
overriding <italic>Tbr1</italic>-dependent mechanism (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
</sec>
<sec id="S17">
<title><italic>Tbr1</italic> Promotion of WNT Signaling Drives Dendritic Spine
Maturation and Synaptogenesis on Layer 5 and Layer 6 Pyramidal Neurons</title>
<p id="P46">WNT signaling is essential in postsynaptic differentiation of excitatory
synapses by recruiting NMDA receptors via promoting PSD95 clustering and local
activation of CaMKII within dendritic spines (<xref ref-type="bibr" rid="R13">Ciani et al., 2011</xref>). Furthermore, CaMKII is required for
WNT-mediated spine growth and increased synaptic strength, thus promoting
postsynaptic maturation and differentiation (<xref ref-type="bibr" rid="R13">Ciani et al., 2011</xref>). Moreover, WNT expression increases microtubule
unbundling and stability by signaling through the canonical pathways downstream
of GSK3β (<xref ref-type="bibr" rid="R12">Ciani et al., 2004</xref>). WNT
inhibition of GSK3β results in phosphorylation of microtubule-associated
proteins such as MAP1B. This interaction is essential for microtubule assembly,
axonal arborization and outgrowth (<xref ref-type="bibr" rid="R12">Ciani et al.,
2004</xref>).</p>
<p id="P47">Transcriptomic and ISH analyses demonstrate that <italic>Tbr1</italic>
promotes expression of <italic>Wnt7b</italic> and <italic>Ctnnb1</italic>
(β-catenin) and represses expression of <italic>Gsk3β</italic>.
<italic>Wnt7b</italic> encodes a WNT ligand of the canonical WNT signaling
pathway (<xref ref-type="bibr" rid="R38">Rosso et al., 2005</xref>).
<italic>Ctnnb1</italic> encodes β-catenin, the central intracellular
signaling protein of the canonical WNT signaling pathway (<xref ref-type="bibr" rid="R11">Ciani and Salinas, 2005</xref>). GSK3β is a
ubiquitously expressed kinase that represses the canonical WNT pathway by
targeting β-catenin for ubiquitin-mediated proteasomal degradation (<xref ref-type="bibr" rid="R46">van Noort et al., 2002</xref>). Restoring
<italic>Wnt7b</italic> expression rescued the synaptic deficit in
<italic>Tbr1<sup>layer6</sup></italic> mutant neurons <italic>in
vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>). To test whether <italic>Wnt7b</italic>
is acting through an autocrine or paracrine mechanism, we introduced cortical
interneurons ectopically expressing <italic>Wnt7b</italic> into the deep layers
of <italic>Tbr1<sup>layer6</sup></italic> CKOs. We measured their effect on
synapse density onto apical dendrites of WT and
<italic>Tbr1<sup>layer6</sup></italic> CKO layer 6 neurons (<xref ref-type="supplementary-material" rid="SD5">Figure S9</xref>). Because we did not find
a statistically significant increase in synapse density, we surmise that WNT7B
primarily promotes synaptogenesis cell autonomously onto layer 6 pyramidal
neurons.</p>
<p id="P48">Furthermore, restoring <italic>Kif1a</italic> expression in layer 5
pyramidal neurons rescued synapses in the <italic>Tbr1<sup>layer5</sup></italic>
CKOs in primary cultures of the neonatal cortex. <italic>Kif1a</italic> is a
member of the kinesin family and functions as an anterograde motor protein that
controls vesicle delivery in the assembly and function of synapses (<xref ref-type="bibr" rid="R22">Guedes-Dias et al., 2019</xref>). GSK3β
phosphorylation of kinesins inhibits their activity and thereby reduces
anterograde dendritic transport (<xref ref-type="bibr" rid="R21">Gottschalk et
al., 2017</xref>; <xref ref-type="bibr" rid="R34">Morfini et al.,
2002</xref>). <italic>De novo</italic>
<italic>KIF1A</italic> mutations in human have been associated with intellectual
disability (<xref ref-type="bibr" rid="R35">Ohba et al., 2015</xref>; <xref ref-type="bibr" rid="R50">Yoshikawa et al., 2018</xref>) and hereditary
spastic paraplegia (<xref ref-type="bibr" rid="R37">Pennings et al.,
2020</xref>). In <italic>Drosophila</italic>, loss-of-function mutations in
<italic>KIF1A</italic> homolog <italic>Unc-104</italic> causes defects in
synaptic transmission by disrupting the formation of mature boutons (<xref ref-type="bibr" rid="R51">Zhang et al., 2017</xref>). Thus, the rescue of
the dendritic spine and synaptic deficits in <italic>Tbr1</italic> mutants via
LiCl and GSK3β-in-hibitor treatments could be, in part, attributed to the
enhanced activity of KIF1A proteins as a result of reduced GSK3β
activity.</p>
</sec>
<sec id="S18">
<title>LiCl and GSK3β Inhibitor Rescue Defects in Dendritic Spine and
Synaptic Density in <italic>Tbr1</italic> Mutants</title>
<p id="P49">To further explore the hypothesis that reduced WNT signaling in
<italic>Tbr1</italic> mutants underlies the reduction in synapses, we tested
whether a canonical WNT-signaling pathway agonist, LiCl or GSK3β
inhibitor, could rescue dendritic spine and synapse defects. Among LiCl’s
best validated mechanisms of action is inhibition of GSK3β, a central
kinase in the WNT/β-catenin and AKT pathways (<xref ref-type="bibr" rid="R29">Lenox and Wang, 2003</xref>).</p>
<p id="P50">LiCl or GSK3β-inhibitor treatment (within 24 h) rescued the
dendritic spine density of <italic>Tbr1</italic> mutant neurons in cortical
layers 5 and 6. Furthermore, either LiCl or GSK3β-inhibitor treatment
rescued excitatory and inhibitory synapse numbers within 24 h. Remarkably, a
single dose of LiCl at P30 led to a sustained rescue of synaptic density,
measured 4 weeks after treatment. These results suggest that the
<italic>Tbr1</italic> mutant’s dendrites have most of the machinery
needed to make synapses but have a deficit of the essential signal(s) to
initiate synaptogenesis. Once the LiCl- or GSk3β-inhibitor-induced
synapses are formed, they appear to be relatively stable.</p>
<p id="P51">Corticothalamic axons in the <italic>Tbr1<sup>layer6</sup></italic>
mutants fail to fully arborize within the anterior and anteromedial regions of
the thalamus (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al.,
2018</xref>). This phenotype was also rescued within 24 h of LiCl or
GSK3β-inhibitor treatment, suggesting that the reduced WNT signaling
underlies the defect of axonal elongation and/or arborization in
<italic>Tbr1<sup>layer6</sup></italic> mutants.</p>
<p id="P52">In sum, we postulate that <italic>Tbr1</italic> mutant layer 5 and layer
6 cortical neurons have reduced WNT signaling that underlies their defects in
dendritic spines, synapses, and axonal arborization. LiCl or GSK3β
inhibitor rescues each of these defects, perhaps through promoting WNT
signaling.</p>
</sec>
<sec id="S19">
<title>LiCl Treatment Rescues Social Interaction Deficit in
<italic>Tbr1<sup>layer5</sup></italic> CKOs</title>
<p id="P53">We eliminated <italic>Tbr1</italic>’s function in cortical layer
5 pyramidal neurons. In most cortical areas, a minority of layer 5 neurons
express TBR1, whereas in rostral areas, including the PFC, TBR1 is expressed in
~85% of layer 5 excitatory neurons (<xref ref-type="supplementary-material" rid="SD5">Figure S1</xref>). The PFC has a central
function in distributed circuits that control higher cognitive and emotional
functions that are disrupted in neuropsychiatric disorders such as ASD.
<italic>Tbr1<sup>layer5</sup></italic> CKOs are viable and fertile,
allowing us to study the impact of <italic>Tbr1</italic> deletion on the
behavior of heterozygous and homozygous CKOs. The
<italic>Tbr1<sup>layer5</sup></italic> CKOs showed no deficit in their motor
functions (rotarod and open field) and interest in novel objects. However,
<italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs showed a
reduction in social interaction with a juvenile mouse. This phenotype had
previously been demonstrated in mice with <italic>Tbr1</italic>
haploinsufficiency (<xref ref-type="bibr" rid="R27">Huang et al.,
2014</xref>).</p>
<p id="P54">Importantly, treating <italic>Tbr1<sup>layer5</sup></italic> CKOs with
LiCl at P30 rescued the social deficit of <italic>Tbr1<sup>layer5</sup></italic>
CKOs (measured at P56–P80). Thus, perhaps the LiCl-mediated rescue of
synaptogenesis may underlie the rescue of the social behavior phenotype. In
studies of multiple neuropsychiatric phenotypes, face-valid rodent behavior has,
so far, not proven to be a reliable assay for therapeutics development in humans
(<xref ref-type="bibr" rid="R42">Sestan and State, 2018</xref>). However,
the observation here is notable in that it links a risk-specific mutation to an
identifiable molecular mechanism and circuit level behavior, offering important
traction for future investigations of ASD pathophysiology.</p>
</sec>
<sec id="S20">
<title>Insights into How <italic>Tbr1</italic> May Contribute to ASD
Pathogenesis</title>
<p id="P55">Co-expression network analysis suggests that the <italic>de
novo</italic> mutations of ASD-risk genes are enriched in excitatory
projection neurons of cortical layers 5 and 6 in the PFCs during human mid-fetal
development (<xref ref-type="bibr" rid="R48">Willsey et al., 2013</xref>), cell
types that also express <italic>Tbr1</italic>. The functions of many ASD-risk
genes converge on pathways that control synaptogenesis, synaptic development,
and plasticity (<xref ref-type="bibr" rid="R40">Sanders et al., 2015</xref>).
Thus, in this study, we deleted <italic>Tbr1</italic> in the excitatory neurons
of mouse layer 5 of the mPFC at a stage similar to human mid-fetal
development.</p>
<p id="P56">Our single-cell transcriptomic analysis of FACS-purified layer 5 neurons
from the mPFC revealed that <italic>Tbr1</italic> regulates other ASD genes,
including <italic>Ank2</italic>, <italic>Ap2s1</italic>,
<italic>Ctnnb1</italic>, <italic>Dpysl2</italic>, <italic>Map1a</italic>,
<italic>Rorb</italic>, <italic>Smarcc2</italic> (orthologs of
high-confidence ASD [hcASD] genes), and <italic>Gsk3β</italic> (ortholog
of a probable ASD [pASD] gene) in either <italic>Tbr1<sup>layer5</sup></italic>
heterozygous or homozygous CKOs. <italic>Tbr1<sup>layer5</sup></italic>
heterozygous and homozygous CKOs demonstrated a decrease in dendritic spines and
excitatory and inhibitory synaptic densities and reduced sEPSCs and sIPSCs,
phenotypes that are convergent with <italic>Tbr1<sup>layerr6</sup></italic>
CKOs, and constitutive <italic>Tbr1</italic><sup>+/−</sup>. This suggests
that decreased TBR1 dosage in human may also impair synaptic development and
thereby increase the risk for ASD. While some of the other phenotypes detected
in <italic>Tbr1<sup>layer5</sup></italic> mutants were only present in the
homozygotes, including defects in social interaction, these observations could
have relevance for ASD, as they denote biological processes that could be
altered in <italic>Tbr1</italic> heterozygotes.</p>
</sec>
<sec id="S21">
<title><italic>Tbr1</italic> and <italic>Shank3</italic> Mutants Convergently
Present Synaptic and Physiological Defects</title>
<p id="P57">The complex genetic variation underlying ASD has complicated efforts to
understand the mechanism associated with ASD pathology and therapies. A possible
solution for such complex diversity is to identify core mechanisms, in which
ASD-risk proteins may act convergently on a common pathway (<xref ref-type="bibr" rid="R45">State and Sestan, 2012</xref>). Many mutations are thought
to predispose to idiopathic ASDs by causing primary impairments in synaptic
transmission (<xref ref-type="bibr" rid="R39">Rosti et al., 2014</xref>; <xref ref-type="bibr" rid="R40">Sanders et al., 2015</xref>).</p>
<p id="P58">Reduced or increased <italic>Shank</italic> expression in
<italic>Drosophila</italic> reduces WNT signaling and excitatory synapses
(<xref ref-type="bibr" rid="R24">Harris et al., 2016</xref>). In mouse,
reduced <italic>Shank3</italic> impairs synaptic function by reduction in
dendritic arborization, excitatory synaptic density, synaptic transmission, and
I<sub>h</sub> current (<xref ref-type="bibr" rid="R49">Yi et al.,
2016</xref>). Similarly, <italic>Tbr1</italic> CKOs have evidence for
reduced WNT signaling and have reduced mature spine density and excitatory
synaptic density (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al.,
2018</xref>). Likewise, <italic>Tbr1</italic> CKOs have abnormal
I<sub>h</sub> currents in cortical layer 5 (<xref ref-type="supplementary-material" rid="SD5">Figure S5</xref>) and layer 6 (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>), although, in
<italic>Tbr1</italic> CKOs, I<sub>h</sub> is increased. TBR1 binds to the
<italic>Shank1</italic>, <italic>−2</italic>, and
<italic>−3</italic> loci (P2 TBR1 ChIP-seq data; GEO: GSE119362)
(<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>),
although there are only subtle changes in <italic>Shank</italic> RNA expression
in the <italic>Tbr1</italic> mutants. Thus, synaptic dysfunction and, perhaps,
reduced WNT signaling are common features of mouse <italic>Tbr1</italic> and
<italic>Shank3</italic> mutants; these defects may be the core
pathophysiology of some forms of ASD.</p>
</sec>
<sec id="S22">
<title>LiCl as a Therapy for Neurodevelopmental Disorders that Have Reduced Synapse
Development</title>
<p id="P59">Currently, there are no treatments for ASD that address its core
biological defects. The ability to restore synapse numbers following lithium
administration in the <italic>Tbr1</italic> mutant mice provides an insight to a
possible human therapy, especially given that LiCl has a long history of
clinical use.</p>
<p id="P60">Our study suggests the value of future study of LiCl as a potential
treatment for ASD patients with <italic>TBR1</italic> mutations. If successful,
LiCl could also conceivably prove relevant for ASD syndromes beyond individuals
with TBR1 mutations, particularly where reduced synaptic development is a
central feature. In a clinical case report, LiCl was reported to reverse
clinical regression, stabilize behavioral abnormalities, and restore brain
functioning in two <italic>SHANK3</italic> patients with ASD (<xref ref-type="bibr" rid="R41">Serret et al., 2015</xref>). Additionally, it is plausible
that the mechanisms identified here could be relevant for patients with
<italic>Ank2</italic>, <italic>Ap2s1</italic>, <italic>Ctnnb1</italic>,
<italic>Dpysl2</italic>, <italic>Map1a</italic>, <italic>Rorb</italic>,
<italic>Smarcc2</italic>, and <italic>Gsk3β</italic>. We also showed
that <italic>Tbr1<sup>layer6</sup></italic> CKOs had arborization defects of
their corticothalamic axons that were improved with LiCl, suggesting that LiCl
could also improve presynaptic defects. This is consistent with the evidence
that WNT signaling positively regulated presynaptic and postsynaptic development
(<xref ref-type="bibr" rid="R1">Ahmad-Annuar et al., 2006</xref>; <xref ref-type="bibr" rid="R44">Stamatakou and Salinas, 2014</xref>).</p>
<p id="P61">It is critically important that any hypothesis regarding novel
treatments in ASD be subjected to rigorous blinded clinical testing. This is
particularly the case for an agent such as LiCl, which has well-known long-term
side effects and a narrow therapeutic window. Open-label trials of novel
compounds to treat core symptoms in ASD have repeatedly shown promising results
early (<xref ref-type="bibr" rid="R10">Choi et al., 2011</xref>), only to be
followed almost uniformly by negative well-controlled trials. The foregoing
consideration of potentially relevant biological mechanisms should not be
construed as an immediate clinical recommendation but rather as a justification
for additional in-depth and rigorous studies.</p>
<p id="P62">Finally, it is remarkable that LiCl in <italic>Tbr1</italic> mutant mice
restores dendritic spine density, synaptogenesis, and axon arborization. LiCl
has a rapid action (24 h); furthermore, the effect of a single dose lasts over 4
weeks. However, there were many features of the <italic>Tbr1</italic> mutants
that did not appear to be rescued by LiCl, including increased layer 5 and layer
6 filamentous spine density and layer 6 dendritic morphogenesis. Thus, while
LiCl may have some promise as a therapy, it is improbable that it would fully
rescue normal brain function of ASD patients with <italic>TBR1</italic>
mutations.</p>
</sec>
</sec>
<sec id="S23">
<title>STAR★METHODS</title>
<sec id="S24">
<title>LEAD CONTACT AND MATERIALS AVAILABILITY</title>
<p id="P63">All unique/stable reagents generated in this study are available from
the Lead Contact, Dr. John L. Rubenstein
(<email>john.rubenstein@ucsf.edu</email>), without restrictions.</p>
</sec>
<sec id="S25">
<title>EXPERIMENTAL MODEL AND SUBJECT DETAILS</title>
<sec id="S26">
<title>Animals</title>
<p id="P64">All procedures and animal care were approved and performed in
accordance with the University of California San Francisco Laboratory Animal
Research Center (LARC) guidelines. All strains were maintained on a C57BL/6
background. Animals were housed in a vivarium with a 12hr light, 12hr dark
cycle. Postnatally, experimental animals were kept with their littermates.
For timed pregnancies, noon on the day of the vaginal plug was counted as
embryonic day 0.5.</p>
<p id="P65">The <italic>Tbr1<sup>flox</sup></italic> allele was generated by
inGenious Targeting Laboratory (Ronkonkoma, NY). LoxP sites were inserted
into introns 1 and 3, flanking <italic>Tbr1</italic> exons 2 and 3 (<xref ref-type="bibr" rid="R18">Fazel Darbandi et al., 2018</xref>). To enable
selection of homologous recombinants, the LoxP site in intron 3 was embedded
in a <italic>neo</italic> cassette that was flanked by <italic>Flp</italic>
sites. The <italic>neo</italic> cassette was removed by mating to a
<italic>Flp</italic>-expressing mouse to generate the
<italic>Tbr1<sup>flox</sup></italic> allele. Cre excision removes
exons 2 and 3, including the T-box DNA binding region, similar to the
constitutive null allele (<xref ref-type="bibr" rid="R7">Bulfone et al.,
1998</xref>). <italic>Rbp4-cre</italic> mice (Gensat KL100) were used to
delete <italic>Tbr1</italic> in layer 5 projection neurons.
<italic>tdTomato</italic><sup><italic>fl</italic>/+</sup>
(<italic>Ai14</italic>) mice were crossed with
<italic>Tbr1<sup>f/f</sup></italic> mice and used as an endogenous
reporter. <italic>Tbr1</italic> layer 5 knockout mice
(<italic>Tbr1<sup>layer5</sup></italic> mutant) were generated by
crossing
<italic>Tbr1<sup>f/f</sup></italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
mice with
<italic>Tbr1</italic><sup><italic>f</italic>/+</sup>∷<italic>Rpb4-cre</italic><sup>+</sup>.
The specific gender and age of experimental animals can be found in the
<xref ref-type="sec" rid="S2">Results</xref> section and corresponding
figure legends.</p>
</sec>
</sec>
<sec id="S27">
<title>TRANSGENIC ANIMAL MODELS</title>
<p id="P66">The mouse strains used for this research project,
B6.FVB(Cg)-Tg(Ntsr1-cre)GN220Gsat/Mmucd, RRID:MMRRC_030648-UCD and
B6.FVB(Cg)-Tg(<italic>Rbp4-cre</italic>)KL100Gsat/Mmucd,
RRID:MMRRC_037128-UCD, were obtained from the Mutant Mouse Resource and Research
Center (MMRRC) at University of California at Davis, an NIH-funded strain
repository, and was donated to the MMRRC by MMRRC at UCD, University of
California, Davis. Made from the original strain (MMRRC:032081) donated by
Nathaniel Heintz, Ph.D., The Rockefeller University, GENSAT <ext-link ext-link-type="uri" xlink:href="http://gensat.org/index.html">http://gensat.org/index.html</ext-link> and Charles
Gerfen, Ph.D., National Institutes of Health, National Institute of Mental
Health.</p>
<p id="P67">Information about the generation and genotyping of the transgenic lines
used in this study can be found in the corresponding original studies:
<italic>Rbp4-Cre</italic> (<xref ref-type="bibr" rid="R20">Gong et al.,
2007</xref>), lox-STOP-lox-tdTomato (Ai14;(<xref ref-type="bibr" rid="R31">Madisen et al., 2010</xref>)). Mice were maintained on C57BL/6J
background.</p>
</sec>
<sec id="S28">
<title>METHOD DETAILS</title>
<sec id="S29">
<title>Genomic DNA extraction and genotyping</title>
<p id="P68">Tissue samples were digested in a solution containing 1 mg/mL of
proteinase K, 50 mM Tris-HCl pH 8.0, 100 mM EDTA, 100 mM NaCl and 1% SDS.
Genomic DNA was extracted using a standard ethanol precipitation protocol.
Genotyping was performed with PCR-based assays using purified genomic DNA,
and primer-pair combinations flanking the deleted region and detecting
<italic>Cre</italic> and <italic>tdTomato</italic> alleles.</p>
</sec>
<sec id="S30">
<title>RNA extraction and cDNA synthesis</title>
<p id="P69">Total RNA was extracted from the cortices of wild-type mice at P0
using RNeasy Plus® Mini Kit (QIAGEN) following the
manufacturer’s protocol. First strand cDNA was synthesized using
Superscript reverse transcriptase II following manufacturer’s
protocol (Thermofisher). cDNA library was used as template to clone and
generate <italic>in situ</italic> probes.</p>
</sec>
<sec id="S31">
<title>Single-Cell RNA-sequencing (scRNA-seq) on FAC-Sorted Cells</title>
<p id="P70">Layer specific transcriptome profiling was conducted by using 10X
Chromium scRNA-seq on FAC-Sorted cells from medial prefrontal cortex of
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer5</sup></italic> heterozygous and homozygous
mutants at P5. The medial prefrontal cortex was dissected in HBSS from P5
mice. Cortices were dissociated using a Papain Dissociation System
(Worthington Biochemical Corporation) following manufacturer’s
protocol. tdTomato<sup>+</sup> cells were sorted using BD FACS Aria II Cell
Sorter at Center for Advanced Technology (UCSF). Approximately 20,000
<italic>tdTomato</italic><sup>+</sup> cells were collected from each
sample. Following FAC-sorting, the cell suspensions were centrifuged at 300
× g for 5 min. Cells were washed for a total of 3 times with 1 mL 1X
PBS supplemented with 0.04% BSA. Following the final wash, the cell pellet
was resuspended with 25 μL of 1X PBS supplemented with 0.04% BSA.
Cell concentration for each sample was determined using trypan blue and a
hemocytometer. We targeted to capture approximately 5000 cells per each
genotype to generate scRNA-seq libraries. Single cell RNA-seq was performed
using 10X Chromium Single Cell 3′ Reagent Kit v2 following
manufacturer’s protocol. Library concentration was assessed with
Qubit dsDNA HS Assay Kit following manufacturer’s protocol
(Thermofisher). Library fragment size distribution was examined on the
Agilent Bioanalyzer 2100 (Agilent Technologies) and Agilent High Sensitivity
DNA Kit (Agilent Technologies) following manufacturer’s protocol.
Libraries were sequenced on Hiseq4000 at Center for Advanced Technology
(UCSF).</p>
</sec>
<sec id="S32">
<title>Computational Analysis of FAC-Sorted Layer 5 scRNA-Seq data</title>
<sec id="S33">
<title>Read pre-processing</title>
<p id="P71">Single cell RNA-sequencing libraries were sequenced on Illumina
Hiseq4000 to an average depth of 45K reads per cell. Read quality
control, UMI counting, barcode counting, and alignment to the mouse
reference genome (mm10) were performed using the “cell-ranger
2.0.1” pipeline provided by the manufacturer.</p>
</sec>
<sec id="S34">
<title>Filtering and Normalization</title>
<p id="P72">The initial dataset contained 17,823 cells with an average of
892 genes per cell. Cells with greater than 30% of mitochondrial genes
were removed as this is indicative of poor-quality cells (n = 82). Cells
with fewer than 500 or more than 10,000 unique-molecular-identifier
(UMI) counts were removed as this often represents sequencing errors (n
= 163). Cells with fewer than 500 or more than 3,000 genes were removed
based on the distribution (n = 182). Genes which occurred in less than
0.01% of cells were also removed (n = 13065). The remaining 17,396 cells
and 14,933 genes were used for downstream analysis. No experimental
factors were determined to explain a disproportionate of expression
variance using the Single Cell Analysis Toolkit for gene Expression in R
(scater; v 1.9.15).</p>
<p id="P73">Using the R package Seurat (v 2.3.4), the data was log
normalized for each cell by the total expression and scaled to 10,000
transcripts per cell. Variable genes were identified using the
<italic>FindVariabieGenes()</italic> function which calculates the
average expression and dispersion for each gene, then bins genes and
calculates a z-score for dispersion within each bin. The data was
scaled, centered, and regressed on the percent of mitochondrial gene
content, number of UMI counts, and the number of genes.</p>
</sec>
<sec id="S35">
<title>Cell-type Identification and Clustering</title>
<p id="P74">TSNE was generated using all principal components accounting for
more than 2% of the variance and a clustering resolution of 0.3 which
resulted in 12 clusters (average silhouette width 0.16). Three clusters
were identified as neuronal cells using known markers
<italic>Nrgn</italic>, <italic>Rorb</italic>, and
<italic>Cnih2</italic>.</p>
<p id="P75">The raw data from the three identified neuronal clusters was
retained and filtered again based on the distribution of UMI counts and
the number of genes per cell (N = 11,943). We applied more stringent
filtering to genes by removing mitochondrial genes, ribosomal genes,
pseudogenes, genes that did not occur in 1% of neuronal cells, and genes
with a variation below the median variation across all genes (N =
7,174). The data normalized as described above and TSNE was generated
using all principal components accounting for more than 4% of the
variance and a clustering resolution of 0.3 which resulted in 6 clusters
(average silhouette width 0.15). Two clusters were identified as
atypical cells due to a reduced expression in excitatory neuronal
markers and subsequently removed from downstream DEX analysis.</p>
</sec>
<sec id="S36">
<title>Differential Gene Expression (DEX) Analysis and Gene Ontology
Enrichment</title>
<p id="P76">To identify gene signatures of each genotype, we used MAST and
the zero-inflated regression (zlm) method to compare raw UMI counts
(i.e., non-normalized counts) per gene across the cells in the
population (FDR &lt; 0.05). Genes that pass a 0.05 significant
threshold are considered as significantly differentially expressed (DEX)
genes. Gene Ontology enrichment analysis of common differentially
expressed genes was performed using the R package goseq (v 1.34.1) using
all expressed genes (N = 7,174) as background.</p>
</sec>
<sec id="S37" sec-type="data-availability">
<title>Data and Code Availability</title>
<p id="P77">The data used in this publication have been deposited in
NCBI’s Gene Expression Omnibus (GEO) under accession number
GSE146298 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146298">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146298</ext-link>).
In addition, all the scripts that were used for analyzing scRNA-seq data
as well as the result files are available on <ext-link ext-link-type="uri" xlink:href="https://github.com/aseveritt/Darbandi_TBR1_L5scRNAseq">https://github.com/aseveritt/Darbandi_TBR1_L5scRNAseq</ext-link>.</p>
</sec>
</sec>
<sec id="S38">
<title>Primary Cell Culture and <italic>in vitro</italic> Rescue Assay</title>
<sec id="S39">
<title>Primary Cell Culture</title>
<p id="P78">Cortex was dissected from P0
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer5</sup></italic> homozygous mutants and
dissociated using papain dissociation kit following
manufacturer’s protocol (Worthington). A total of 300,000 cells
were seeded into tissue culture slides pre-coated with poly-L-lysine (10
mg/ml, Sigma) and then laminin (5 mg/ml, Sigma), and grown <italic>in
vitro</italic> with media containing DMEM-H21 with 5% fetal bovine
serum for 3 hr. After the cells recovered, DMEM-H21 media was replaced
by Neurobasal medium containing B27 supplement, 25% glucose, and
glutamax overnight.</p>
</sec>
<sec id="S40">
<title>In vitro <italic>Rescue Assay</italic></title>
<p id="P79"><italic>Syt4</italic>, <italic>Mef2c</italic>,
<italic>Kif1a</italic> and <italic>Rac3</italic> cDNA was cloned
into pcDNA3.1(−) (Thermofisher Scientific).
<italic>Tbr1<sup>layer5</sup></italic> mutant cells were
transfected with <italic>Syt4</italic>, <italic>Mef2c</italic>,
<italic>Kif1a</italic>, <italic>Rac3</italic> expression vectors and
<italic>Tbr1<sup>wild-type</sup></italic> were transfected with
mock empty vector using Lipofectamine 3000 (Invitrogen) for 6 hr.
Following incubation, the media was replaced by Neurobasal medium
containing B27 supplement, Penicillin/Streptomycin, 25% glucose, and
glutamax. Cultures were grown for 14 days <italic>in vitro</italic>.
After 14 days, cultures were washed 3 times with 0.5 mL 1X PBS for 5 min
each and fixed for 15 min with 4% PFA in 1X PBS at RT. Fixed cells were
washed 3 times with 0.5 mL 1X PBS and blocked in 1X PBS containing 10%
Normal Serum, 0.1% Triton X- 100 and 2% BSA for 1 hr at RT. Primary
antibodies including mouse anti-Vglut1 (1:200, Synaptic Systems) and
rabbit anti-PSD95 (1:200, Cell Signaling; excitatory synapses), rabbit
anti-Vgat (1:500, Synaptic Systems) and mouse anti-gephyrin (1:200,
Synaptic Systems; inhibitory synapses) were diluted 1:200 in blocking
solution. Cells were stained for excitatory and inhibitory synapses with
primary antibodies for 48 hr at 4°C with gentle shaking. On a
shaker, the cells were washed 3 times with 0.5 mL 1X PBS for 5 min each
and incubated with the secondary antibody for 2 hr (room temperature),
washed 3X with 1X PBS, and mounted. This experiment was repeated twice
(n = 2).</p>
</sec>
</sec>
<sec id="S41">
<title><italic>In vivo</italic> Synapse Rescue Assays</title>
<p id="P80">We performed <italic>in vivo</italic> rescue assay of synaptic
deficit in <italic>Tbr1</italic> mutant mice using three different
approaches. First, we directly injected a lentivirus harboring WNT7B.
Second, we utilized a transplantation assay to deliver the protein of
interest (WNT7B) by introducing MGE progenitor cells, following previously
published MGE transplantation assay (<xref ref-type="bibr" rid="R47">Vogt et
al., 2015</xref>). Lastly, we used a single intraperitoneal injection of
LiCl to rescue the decrease in synapse numbers in <italic>Tbr1</italic>
mutants.</p>
<sec id="S42">
<title>Direct lentiviral injection</title>
<p id="P81"><italic>In vivo</italic> rescue assay was carried out by cloning
<italic>Wnt7b</italic> into a <italic>Cre</italic>-dependent
lentiviral backbone
(<italic>pLenti</italic>-<italic>CAG-Flex-IRES-GFP</italic>).
<italic>CAG-Flex-GFP</italic> (empty vector) and
<italic>Wnt7b-IRES-GFP</italic> expressing lentivirus
(<italic>pLenti-CAG-Flex-Wnt7b-IRES-GFP</italic>) were generated in
HEK293T cells as previously reported (<xref ref-type="bibr" rid="R47">Vogt et al., 2015</xref>) using Polyplus jetPRIMEH®
transfection reagent following manufacturer’s protocol.</p>
<p id="P82">Lentivirus containing <italic>CAG-Flex-GFP</italic> or
<italic>Wnt7b-IRES-GFP</italic> were injected in the SSCx of
<italic>Tbr1<sup>layer6</sup></italic> wild-type as well as
<italic>Tbr1<sup>layer6</sup></italic> heterozygous and
homozygous CKO pups at P1. For injections, a glass micropipette of 50
μm diameter (with a beveled tip) was preloaded with sterile
mineral oil and viral suspension was front-loaded into the tip of the
needle using a plunger connected to a hydraulic drive (Narishige) that
was mounted to a stereotaxic frame. P1 pups from
<italic>Tbr1<sup>layer6</sup></italic> wild-type and
<italic>Tbr1<sup>layer6</sup></italic> heterozygous and
homozygous CKOs were anesthetized on ice for 1–2 min before
injections. Each pup received 2–3 viral injections (150 nL per
site) in the right hemisphere. These sites were about 1 mm apart along
the rostral to caudal axis. Viral suspensions were injected into layer 6
of the neonatal SSCx. After injections, pups were put back with the
mother to recover after they began to move around on their own. Mice
were sacrificed 21 days after injection and transcardially perfused with
PBS followed by 4% PFA.</p>
</sec>
<sec id="S43">
<title>MGE-Derived Interneuron Transplantation Assay</title>
<p id="P83">A detailed protocol for the MGE transplantation assay has been
previously described (<xref ref-type="bibr" rid="R47">Vogt et al.,
2015</xref>). First, E13.5 MGEs from
<italic>Nkx2.1-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
embryos were dissected in ice-cold HBSS. Next, cells were mechanically
dissociated by repeated pipetting (10–15 times) through a 1000
μL plastic pipette tip in DMEM media that contained 10% fetal
bovine serum. Cells were dissociated in DMEM with 10% FBS that was
preconditioned in a tissue culture incubator at 37°C and with 5%
CO<sub>2</sub> to achieve a physiological pH. The cells were then
transfected with either <italic>DlxI12b-GFP</italic> (control) or
<italic>DlxI12b-Wnt7b-GFP</italic> (WNT7B-GFP expressing). Cells
were transfected for 30 min at 37°C then pelleted by
centrifugation (3 min, 700 × g), and resuspended in 2-3 μL
of DMEM, put on ice, and then remaining media containing the transfected
MGE cells was removed before loaded into the injection needle. For
injections, a glass micropipette of 50 μm diameter (with a
beveled tip) was preloaded with sterile mineral oil and cells were
front-loaded into the tip of the needle using a plunger connected to a
hydraulic drive (Narishige) that was mounted to a stereotaxic frame.
<italic>Tbr1<sup>layer6</sup></italic> Wild-type and
<italic>Tbr1<sup>layer6</sup></italic> homozygous CKO P1 pups
were anesthetized on ice for 1-2 min before being placed into a molded
surface (modeling clay) for injections. Each pup received 2-3 injections
of cells (~100 nL per site) in the right hemisphere. These sites
were about 1mm apart along the rostral to caudal axis; cells were
injected into layers 5/6 of the neocortex. After injections, pups were
put back with the mother to recover after they began to move around on
their own. Mice were sacrificed 28 days after transplantation and
transcardially perfused with PBS followed by 4% PFA.</p>
</sec>
<sec id="S44">
<title>Lithium chloride (LiCl) injection</title>
<p id="P84">P59 and P30 mice were administered a single intraperitoneal (IP)
injection of 400 mg/kg LiCl or saline in a volume of 4 ml/kg (<xref ref-type="bibr" rid="R32">Martin et al., 2018</xref>). Treated mice
were anesthetized at P60, 24 hr or 4 weeks after LiCl injection with
intraperitoneal injection of 100 mg/kg Ketamine containing 15 mg/kg
Xylazine. A separate cohort of P58 mice were administered a single IP
injection of 400 mg/kg LiCl or saline in a volume of 4 ml/kg. Treated
mice were anesthetized 24 hr after LiCl injection with intraperitoneal
injection 100 mg/kg Ketamine containing 15 mg/kg Xylazine. All brains
were processed at P60. Animals were perfused transcardially with
ice-cold 1X PBS and then with 4% PFA in 1X PBS, followed by brain
isolation, 1-2 hr post-fixation, cryoprotected in 30% sucrose in PBS,
and cut frozen (coronally or sagittally) on a sliding microtome at
40μm for immunohistochemistry.</p>
</sec>
</sec>
<sec id="S45">
<title>Histology</title>
<p id="P85">For P0 and P3 experiments, neonatal animals were anesthetized on
ice. For P21 and P56 experiments, animals were anesthetized with
intraperitoneal injection of 100 mg/kg Ketamine containing 15 mg/kg
Xylazine. Animals were perfused transcardially with cold PBS and then with
4% PFA in PBS, followed by brain isolation, 1-2 hr post-fixation,
cryoprotected in 30% sucrose in PBS, and cut frozen (coronally or
sagittally) on a sliding microtome at 40μm for immunohistochemistry
or <italic>in situ</italic> hybridization. All primary and secondary
antibodies were diluted in PBS containing 10% Normal Serum, 0.25% Triton
X-100 and 2% BSA. The following primary antibodies were used: mouse
anti-Vglut1 (1:200, Synaptic Systems), rabbit anti-Vgat (1:500, Synaptic
Systems), rabbit anti-PSD95 (1:200, Cell Signaling), mouse anti-gephyrin
(1:200, Synaptic Systems). The secondary antibodies for immunofluorescence
were Alexa Fluor-conjugated and purchased from Thermofisher. For <italic>in
vivo</italic> synapse immunohistochemistry, a total of n = 30 apical
dendrites were counted from each of
<italic>Tbr1<sup>wild-type</sup></italic>,
<italic>Tbr1<sup>layer5</sup></italic> heterozygous and
<italic>Tbr1<sup>layer5</sup></italic> homozygous mutants. The
coronal sections were pre-treated with pepsin to enhance the staining.
Immunofluorescence specimens were counterstained with 1% DAPI to assist the
delineation of cortical layers. For <italic>in situ</italic> hybridization a
rostro-caudal coronal series of at least ten sections from n = 2 brains from
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer5</sup></italic> heterozygous and homozygous
mutants were examined. Anti-sense riboprobes for <italic>Calm2</italic>,
<italic>Kif1a</italic>, <italic>Wnt7b</italic>, and
<italic>Mgst3</italic> were prepared as previously described (<xref ref-type="bibr" rid="R14">Cobos et al., 2005</xref>; <xref ref-type="bibr" rid="R17">Fazel Darbandi et al., 2016</xref>). We also
investigated cortical lamination within rostral cortex including PFCx of
wild-type brain at P3 and P21 using anti-sense riboprobes for lamination
markers <italic>Cux2</italic>, <italic>Rorb</italic>, <italic>Etv1</italic>,
<italic>Tbr1</italic> and <italic>Nr4a2</italic>. ISH was performed
using digoxigenin-labeled riboprobes.</p>
</sec>
<sec id="S46">
<title>Image Acquisition and Analysis</title>
<p id="P86">Fluorescent and bright-field images were taken using a Coolsnap
camera (Photometrics) mounted on a Nikon Eclipse 80i microscope using NIS
Elements acquisition software (Nikon). Confocal imaging experiments were
conducted at the Cancer Research Laboratory (CRL) Molecular Imaging Center,
supported by Helen Wills Neuroscience Institute at UC Berkeley. Confocal
images were acquired using Zeiss LSM 880 with Airyscan with a 63X objective
at 1,024 × 1,024 pixels resolution with 2.0X optical zoom using ZEN
2.0 software. Brightness and contrast were adjusted, and images merged using
Photoshop or ImageJ software. ImageJ software was used for image processing.
For synapse counting (presynaptic and postsynaptic boutons), confocal image
stacks (0.4μm step size) were processed with ImageJ software. In
brief, background subtraction and smooth filter were applied to each stack.
Using a threshold function, each stack was converted into a
‘masks’ image. Furthermore, the channels were co-localized
with the Image Calculator plugging. Lastly, the number of co-localizations
were counted, and the length of each dendrite was measured in each of the
focal plane. Staining for control and mutant were done in parallel as well
as the image capturing.</p>
</sec>
<sec id="S47">
<title>Electrophysiology</title>
<p id="P87">Coronal brain slices (250 μm) including medial prefrontal
cortex were made from three mice (n = 3) at age p21-28 and at p56-p80.
Slicing solution was chilled to 4°C and contained (in mM): 234
sucrose, 26 NaHCO<sub>3</sub>, 11 glucose, 10 MgSO<sub>4</sub>, 2.5 KCl,
1.25 NaH<sub>2</sub>PO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, bubbled with 5%
CO<sub>2</sub>/ 95% O<sub>2</sub>. Slices were incubated in artificial
cerebrospinal fluid (aCSF) at 32°C for 30 minutes and then at room
temperature until recording. aCSF contained (in mM): 123 NaCl, 26
NaHCO<sub>3</sub>, 11 glucose, 3 KCl, 2 CaCl<sub>2</sub>, 1.25
NaH<sub>2</sub>PO<sub>4</sub>, 1 MgCl<sub>2</sub>, also bubbled with 5%
CO<sub>2</sub>/ 95% O<sub>2</sub>. Neurons were visualized using
differential interference contrast or DODT contrast microscopy on an upright
microscope (Olympus). <italic>Rbp4-cre</italic> positive neurons were
identified by fluorescent visualization of cre-dependent tdTomato. We
obtained somatic whole-cell patch clamp recordings using a Multiclamp 700B
(Molecular Devices) amplifier and acquired with pClamp. Patch pipettes (2-5
MΩ tip resistance) were filled with the following (in mM): 130
KGluconate, 10 KCl, 10 HEPES, 10 EGTA, 2 MgCl<sub>2</sub>, 2 MgATP, 0.3
Na<sub>3</sub>GTP. All recordings were made at 32-34°C. Series
resistance was compensated in all current clamp experiments and monitored
throughout recordings. Recordings were discarded if Rs changed by &gt;
25%. For spontaneous EPSC and IPSC recordings cells were held in voltage
clamp at −70 mV and +10mV, respectively. In both cases patch pipettes
were filled with the following (in mM): 135 Cesium Methanesulfonate, 8 NaCl,
10 HEPES, 0.3 EGTA, 5 QX314, 4 MgATP, 0.3 Na<sub>3</sub>GTP.</p>
</sec>
<sec id="S48">
<title>Behavioral Assays</title>
<p id="P88">Experiments were conducted during the light cycle (8am to 8pm). Mice
were habituated to investigator handling for 1-2min on three consecutive
days. On the testing day, mice were transferred to experimental room and
allowed to habituate for at least 45 minutes prior to testing. All behavior
assays were performed on mice age P56 to P80. We were blind to the genotypes
during scoring of videos.</p>
<sec id="S49">
<title>Open-field test</title>
<p id="P89">An individual mouse was placed near the wall-side of 50 ×
50 cm open-field arena, and the movement of the mouse was recorded by a
video camera for 10 min. The recorded video file was analyzed with
Any-Maze software (San Diego Instruments). Time in the center of the
field (a 25 × 25 cm square) was measured. The open field arena
was cleaned with 70% ethanol and wiped with paper towels between each
trial.</p>
</sec>
<sec id="S50">
<title>Elevated plus maze test</title>
<p id="P90">An individual mouse was placed at the junction of the open and
closed arms, facing the arm opposite to the experimenter, of an
apparatus with two open arms without walls (30 × 5 × 0.5
cm) across from each other and perpendicular to two closed arms with
walls (30 × 5 × 15 cm) with a center platform (5 ×
5 cm), and at a height of 40 cm above the floor. The movement of the
mouse was recorded by a video camera for 10 min. The recorded video file
was analyzed with Any-Maze software and time in the open arms of the
apparatus was measured. The arms of the elevated plus maze apparatus was
cleaned with 70% ethanol and wiped with paper towels between each
trial.</p>
</sec>
<sec id="S51">
<title>Rotarod test</title>
<p id="P91">The assay consisted of four trials per day over the course of 2
days with the rotarod set to accelerate from 4rpm to 45rpm over 5
minutes. The trial started once five mice were placed on the rotarod
rotating at 4rpm in separate partitioned compartments. Each trial ended
when a mouse fell off, made three complete revolutions while hanging on,
or reached 300 s. Digital videos of the mice on the rotarod were
recorded from behind. The rotarod apparatus was cleaned with 70% ethanol
and wiped with paper towels between each trial.</p>
</sec>
<sec id="S52">
<title>Social interaction and novel object task</title>
<p id="P92">An individual mouse was allowed to habituate for 5 minutes in
their home cage prior to starting the trial. A juvenile (3-4 weeks old)
mouse of the same strain and sex was introduced to the home cage. After
5 minutes, the juvenile was removed from the home cage. After a 5 min
break a novel object (typically a plastic test tube cap) was introduced
into the home cage for five minutes. We scored videos offline, blind to
genotype. We measured the number of seconds the mouse spent with its
nose in direct contact with the novel object or engaged in social
interaction with the juvenile (defined as sniffing, close following, or
allo-grooming) in the 300 s following the time the juvenile or object
was introduced into the cage. In addition, we noted any
aggressive-appearing behaviors toward the juvenile, freezing, and
grooming behaviors. We repeated this behavioral assay on adult wild-type
and mutant mice that were treated with a single IP injection of LiCl and
compared to vehicle treated animals injected with saline.</p>
</sec>
</sec>
</sec>
<sec id="S53">
<title>QUANTIFICATION AND STATISTICAL ANALYSIS</title>
<p id="P93">All individual data points are shown as well as mean ± SEM. All
statistical analyses were performed using GraphPad Prism 7.0 software.
Statistical significance was accepted at the level p &lt; 0.05. We used
Student’s t test to compare pairs of groups if data were normally
distributed (verified using Lillie test). If more than two groups were compared,
we used one-way ANOVA with post hoc tests between groups corrected for multiple
comparisons (Holm-Sidak or Tukey). Forthe ISH experiments reported in this paper
n = 2 represents two biological replicates for each of the reported genes. We
examined the changes in synapse numbers of n = 30 different dendrites from n = 2
animals for each genotype. Whole-cell patch clamp experiments at P21 and P56
were conducted from n = 3 different animals for each age and genotype. Lastly,
behavioral analysis was conducted from n = 11/8/9, wild-type/
heterozygous/homozygous animals. The specific n for each experiment as well as
the post hoc test, exact F and corrected p values can be found in the <xref ref-type="sec" rid="S2">Results</xref> section.</p>
</sec>
<sec id="S54" sec-type="data-availability">
<title>DATA AND CODE AVAILABILITY</title>
<p id="P94">Data and MATLAB analysis scripts are available upon request from the
Lead Contact.</p>
</sec>
</sec>
<sec id="SM1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supp Info 1</label>
<media id="d39e3175" orientation="portrait" position="anchor" xlink:href="NIHMS1622004-supplement-Supp_Info_1.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supp Info 2</label>
<media id="d39e3179" orientation="portrait" position="anchor" xlink:href="NIHMS1622004-supplement-Supp_Info_2.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Supp Info 3</label>
<media id="d39e3183" orientation="portrait" position="anchor" xlink:href="NIHMS1622004-supplement-Supp_Info_3.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Supp Info 4</label>
<media id="d39e3187" orientation="portrait" position="anchor" xlink:href="NIHMS1622004-supplement-Supp_Info_4.xlsx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>5</label>
<media id="d39e3191" orientation="portrait" position="anchor" xlink:href="NIHMS1622004-supplement-5.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S55">
<title>ACKNOWLEDGMENTS</title>
<p id="P95">This work was supported by research grants to J.L.R.R. from the Nina
Ireland, NINDS (R01 NS34661 and R01 NS099099), and the Simons Foundation (630332);
and to V.S.S. from the NIMH (R01MH100292 and R01MH106507).</p>
</ack>
<fn-group>
<fn id="FN2">
<p id="P96">SUPPLEMENTAL INFORMATION</p>
<p id="P97">Supplemental Information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2020.03.059">https://doi.org/10.1016/j.celrep.2020.03.059</ext-link>.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P98">DECLARATION OF INTERESTS</p>
<p id="P99">J.L.R.R. is cofounder and stockholder, and currently on the scientific
board, of Neurona, a company studying the potential therapeutic use of
interneuron transplantation. A.J.W. is a paid consultant for Daiichi Sankyo.
M.W.S. is a consultant to BlackThorn and ArRett Pharmaceuticals. All other
authors declare no competing interests.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<mixed-citation publication-type="journal"><name><surname>Ahmad-Annuar</surname><given-names>A</given-names></name>, <name><surname>Ciani</surname><given-names>L</given-names></name>, <name><surname>Simeonidis</surname><given-names>I</given-names></name>, <name><surname>Herreros</surname><given-names>J</given-names></name>, <name><surname>Fredj</surname><given-names>NB</given-names></name>, <name><surname>Rosso</surname><given-names>SB</given-names></name>, <name><surname>Hall</surname><given-names>A</given-names></name>, <name><surname>Brickley</surname><given-names>S</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2006</year>). <article-title>Signaling across the synapse: a role
for Wnt and Dishevelled in presynaptic assembly and neurotransmitter
release</article-title>. <source/>J. Cell Biol
<volume>174</volume>,
<fpage>127</fpage>–<lpage>139</lpage>.<pub-id pub-id-type="pmid">16818724</pub-id></mixed-citation>
</ref>
<ref id="R2">
<mixed-citation publication-type="journal"><name><surname>Barber</surname><given-names>CF</given-names></name>, <name><surname>Jorquera</surname><given-names>RA</given-names></name>, <name><surname>Melom</surname><given-names>JE</given-names></name>, and <name><surname>Littleton</surname><given-names>JT</given-names></name> (<year>2009</year>). <article-title>Postsynaptic regulation of synaptic
plasticity by synaptotagmin 4 requires both C2 domains</article-title>.
<source/>J. Cell Biol
<volume>187</volume>,
<fpage>295</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">19822673</pub-id></mixed-citation>
</ref>
<ref id="R3">
<mixed-citation publication-type="journal"><name><surname>Barbosa</surname><given-names>AC</given-names></name>, <name><surname>Kim</surname><given-names>M-S</given-names></name>, <name><surname>Ertunc</surname><given-names>M</given-names></name>, <name><surname>Adachi</surname><given-names>M</given-names></name>, <name><surname>Nelson</surname><given-names>ED</given-names></name>, <name><surname>McAnally</surname><given-names>J</given-names></name>, <name><surname>Richardson</surname><given-names>JA</given-names></name>, <name><surname>Kavalali</surname><given-names>ET</given-names></name>, <name><surname>Monteggia</surname><given-names>LM</given-names></name>, <name><surname>Bassel-Duby</surname><given-names>R</given-names></name>, and <name><surname>Olson</surname><given-names>EN</given-names></name> (<year>2008</year>). <article-title>MEF2C, a transcription factor that
facilitates learning and memory by negative regulation of synapse numbers
and function</article-title>. <source/>Proc. Natl. Acad. Sci. USA
<volume>105</volume>,
<fpage>9391</fpage>–<lpage>9396</lpage>.<pub-id pub-id-type="pmid">18599438</pub-id></mixed-citation>
</ref>
<ref id="R4">
<mixed-citation publication-type="journal"><name><surname>Bedogni</surname><given-names>F</given-names></name>, <name><surname>Hodge</surname><given-names>RD</given-names></name>, <name><surname>Elsen</surname><given-names>GE</given-names></name>, <name><surname>Nelson</surname><given-names>BR</given-names></name>, <name><surname>Daza</surname><given-names>RAM</given-names></name>, <name><surname>Beyer</surname><given-names>RP</given-names></name>, <name><surname>Bammler</surname><given-names>TK</given-names></name>, <name><surname>Rubenstein</surname><given-names>JLR</given-names></name>, and <name><surname>Hevner</surname><given-names>RF</given-names></name> (<year>2010</year>). <article-title>Tbr1 regulates regional and laminar
identity of postmitotic neurons in developing neocortex</article-title>.
<source/>Proc. Natl. Acad. Sci. USA
<volume>107</volume>,
<fpage>13129</fpage>–<lpage>13134</lpage>.<pub-id pub-id-type="pmid">20615956</pub-id></mixed-citation>
</ref>
<ref id="R5">
<mixed-citation publication-type="journal"><name><surname>Budnik</surname><given-names>V</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2011</year>). <article-title>Wnt signaling during synaptic
development and plasticity</article-title>. <source/>Curr. Opin.
Neurobiol
<volume>21</volume>,
<fpage>151</fpage>–<lpage>159</lpage>.<pub-id pub-id-type="pmid">21239163</pub-id></mixed-citation>
</ref>
<ref id="R6">
<mixed-citation publication-type="journal"><name><surname>Bulfone</surname><given-names>A</given-names></name>, <name><surname>Smiga</surname><given-names>SM</given-names></name>, <name><surname>Shimamura</surname><given-names>K</given-names></name>, <name><surname>Peterson</surname><given-names>A</given-names></name>, <name><surname>Puelles</surname><given-names>L</given-names></name>, and <name><surname>Rubenstein</surname><given-names>JLR</given-names></name> (<year>1995</year>). <article-title>T-brain-1: a homolog of Brachyury
whose expression defines molecularly distinct domains within the cerebral
cortex</article-title>. <source/>Neuron
<volume>15</volume>,
<fpage>63</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">7619531</pub-id></mixed-citation>
</ref>
<ref id="R7">
<mixed-citation publication-type="journal"><name><surname>Bulfone</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Hevner</surname><given-names>R</given-names></name>, <name><surname>Anderson</surname><given-names>S</given-names></name>, <name><surname>Cutforth</surname><given-names>T</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Meneses</surname><given-names>J</given-names></name>, <name><surname>Pedersen</surname><given-names>R</given-names></name>, <name><surname>Axel</surname><given-names>R</given-names></name>, and <name><surname>Rubenstein</surname><given-names>JLR</given-names></name> (<year>1998</year>). <article-title>An olfactory sensory map develops in
the absence of normal projection neurons or GABAergic
interneurons</article-title>. <source/>Neuron
<volume>21</volume>,
<fpage>1273</fpage>–<lpage>1282</lpage>.<pub-id pub-id-type="pmid">9883721</pub-id></mixed-citation>
</ref>
<ref id="R8">
<mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>N</given-names></name>, and <name><surname>Napoli</surname><given-names>JL</given-names></name> (<year>2008</year>). <article-title>All-trans-retinoic acid stimulates
translation and induces spine formation in hippocampal neurons through a
membrane-associated RARalpha</article-title>. <source/>FASEB J.
<volume>22</volume>,
<fpage>236</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">17712061</pub-id></mixed-citation>
</ref>
<ref id="R9">
<mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Lau</surname><given-names>AG</given-names></name>, and <name><surname>Sarti</surname><given-names>F</given-names></name> (<year>2014</year>). <article-title>Synaptic retinoic acid signaling and
homeostatic synaptic plasticity</article-title>.
<source/>Neuropharmacology
<volume>78</volume>, <fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">23270606</pub-id></mixed-citation>
</ref>
<ref id="R10">
<mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>CH</given-names></name>, <name><surname>Schoenfeld</surname><given-names>BP</given-names></name>, <name><surname>Bell</surname><given-names>AJ</given-names></name>, <name><surname>Hinchey</surname><given-names>P</given-names></name>, <name><surname>Kollaros</surname><given-names>M</given-names></name>, <name><surname>Gertner</surname><given-names>MJ</given-names></name>, <name><surname>Woo</surname><given-names>NH</given-names></name>, <name><surname>Tranfaglia</surname><given-names>MR</given-names></name>, <name><surname>Bear</surname><given-names>MF</given-names></name>, <name><surname>Zukin</surname><given-names>RS</given-names></name>, <etal></etal> (<year>2011</year>). <article-title>Pharmacological reversal of
synaptic plasticity deficits in the mouse model offragile X syndrome by
group II mGluR antagonist or lithium treatment</article-title>.
<source/>Brain Res.
<volume>1380</volume>,<fpage>106</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">21078304</pub-id></mixed-citation>
</ref>
<ref id="R11">
<mixed-citation publication-type="journal"><name><surname>Ciani</surname><given-names>L</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2005</year>). <article-title>WNTs in the vertebrate nervous
system: from patterning to neuronal connectivity</article-title>.
<source/>Nat. Rev. Neurosci
<volume>6</volume>,
<fpage>351</fpage>–<lpage>362</lpage>.<pub-id pub-id-type="pmid">15832199</pub-id></mixed-citation>
</ref>
<ref id="R12">
<mixed-citation publication-type="journal"><name><surname>Ciani</surname><given-names>L</given-names></name>, <name><surname>Krylova</surname><given-names>O</given-names></name>, <name><surname>Smalley</surname><given-names>MJ</given-names></name>, <name><surname>Dale</surname><given-names>TC</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2004</year>). <article-title>A divergent canonical WNT-signaling
pathway regulates microtubule dynamics: Dishevelled signals locally to
stabilize microtubules</article-title>. <source/>J. Cell Biol
<volume>164</volume>,
<fpage>243</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">14734535</pub-id></mixed-citation>
</ref>
<ref id="R13">
<mixed-citation publication-type="journal"><name><surname>Ciani</surname><given-names>L</given-names></name>, <name><surname>Boyle</surname><given-names>KA</given-names></name>, <name><surname>Dickins</surname><given-names>E</given-names></name>, <name><surname>Sahores</surname><given-names>M</given-names></name>, <name><surname>Anane</surname><given-names>D</given-names></name>, <name><surname>Lopes</surname><given-names>DM</given-names></name>, <name><surname>Gibb</surname><given-names>AJ</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2011</year>). <article-title>Wnt7a signaling promotes dendritic
spine growth and synaptic strength through
Ca<sup>2+</sup>/calmodulin-dependent protein kinase II</article-title>.
<source/>Proc. Natl. Acad. Sci. USA
<volume>108</volume>,
<fpage>10732</fpage>–<lpage>10737</lpage>.<pub-id pub-id-type="pmid">21670302</pub-id></mixed-citation>
</ref>
<ref id="R14">
<mixed-citation publication-type="journal"><name><surname>Cobos</surname><given-names>I</given-names></name>, <name><surname>Calcagnotto</surname><given-names>ME</given-names></name>, <name><surname>Vilaythong</surname><given-names>AJ</given-names></name>, <name><surname>Thwin</surname><given-names>MT</given-names></name>, <name><surname>Noebels</surname><given-names>JL</given-names></name>, <name><surname>Baraban</surname><given-names>SC</given-names></name>, and <name><surname>Rubenstein</surname><given-names>JL</given-names></name> (<year>2005</year>). <article-title>Mice lacking Dlx1 show
subtype-specific loss of interneurons, reduced inhibition and
epilepsy</article-title>. <source/>Nat. Neurosci
<volume>8</volume>,
<fpage>1059</fpage>–<lpage>1068</lpage>.<pub-id pub-id-type="pmid">16007083</pub-id></mixed-citation>
</ref>
<ref id="R15">
<mixed-citation publication-type="journal"><name><surname>Dembrow</surname><given-names>NC</given-names></name>, <name><surname>Chitwood</surname><given-names>RA</given-names></name>, and <name><surname>Johnston</surname><given-names>D</given-names></name> (<year>2010</year>). <article-title>Projection-specific neuromodulation
of medial prefrontal cortex neurons</article-title>. <source/>J.
Neurosci
<volume>30</volume>,
<fpage>16922</fpage>–<lpage>16937</lpage>.<pub-id pub-id-type="pmid">21159963</pub-id></mixed-citation>
</ref>
<ref id="R16">
<mixed-citation publication-type="journal"><name><surname>Farooq</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>S</given-names></name>, <name><surname>Khatri</surname><given-names>L</given-names></name>, <name><surname>Hikima</surname><given-names>T</given-names></name>, <name><surname>Rice</surname><given-names>ME</given-names></name>, and <name><surname>Ziff</surname><given-names>EB</given-names></name> (<year>2017</year>). <article-title>Lithium increases synaptic GluA2 in
hippocampal neurons by elevating the δ-catenin
protein</article-title>. <source/>Neuropharmacology
<volume>113</volume> (<issue>Pt A</issue>),
<fpage>426</fpage>–<lpage>433</lpage>.<pub-id pub-id-type="pmid">27793771</pub-id></mixed-citation>
</ref>
<ref id="R17">
<mixed-citation publication-type="journal"><name><surname>Fazel Darbandi</surname><given-names>S</given-names></name>, <name><surname>Poitras</surname><given-names>L</given-names></name>, <name><surname>Monis</surname><given-names>S</given-names></name>, <name><surname>Lindtner</surname><given-names>S</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Hatch</surname><given-names>G</given-names></name>, <name><surname>Rubenstein</surname><given-names>JL</given-names></name>, and <name><surname>Ekker</surname><given-names>M</given-names></name> (<year>2016</year>). <article-title>Functional consequences of I56ii Dlx
enhancer deletion in the developing mouse forebrain</article-title>.
<source/>Dev. Biol
<volume>420</volume>,
<fpage>32</fpage>–<lpage>42</lpage>.</mixed-citation>
</ref>
<ref id="R18">
<mixed-citation publication-type="journal"><name><surname>Fazel Darbandi</surname><given-names>S</given-names></name>, <name><surname>Robinson Schwartz</surname><given-names>SE</given-names></name>, <name><surname>Qi</surname><given-names>Q</given-names></name>, <name><surname>Catta-Preta</surname><given-names>R</given-names></name>, <name><surname>Pai</surname><given-names>EL-L</given-names></name>, <name><surname>Mandell</surname><given-names>JD</given-names></name>, <name><surname>Everitt</surname><given-names>A</given-names></name>, <name><surname>Rubin</surname><given-names>A</given-names></name>, <name><surname>Krasnoff</surname><given-names>RA</given-names></name>, <name><surname>Katzman</surname><given-names>S</given-names></name>, <etal></etal> (<year>2018</year>). <article-title>Neonatal
<italic>Tbr1</italic> dosage controls cortical layer 6
connectivity</article-title>. <source/>Neuron
<volume>100</volume>,
<fpage>831</fpage>–<lpage>845.e7</lpage>.<pub-id pub-id-type="pmid">30318412</pub-id></mixed-citation>
</ref>
<ref id="R19">
<mixed-citation publication-type="journal"><name><surname>Goldberg</surname><given-names>JL</given-names></name> (<year>2003</year>). <article-title>How does an axon
grow?</article-title>
<source/>Genes Dev. <volume>17</volume>,
<fpage>941</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">12704078</pub-id></mixed-citation>
</ref>
<ref id="R20">
<mixed-citation publication-type="journal"><name><surname>Gong</surname><given-names>S</given-names></name>, <name><surname>Doughty</surname><given-names>M</given-names></name>, <name><surname>Harbaugh</surname><given-names>CR</given-names></name>, <name><surname>Cummins</surname><given-names>A</given-names></name>, <name><surname>Hatten</surname><given-names>ME</given-names></name>, <name><surname>Heintz</surname><given-names>N</given-names></name>, and <name><surname>Gerfen</surname><given-names>CR</given-names></name> (<year>2007</year>). <article-title>Targeting Cre recombinase to
specific neuron populations with bacterial artificial chromosome
constructs</article-title>. <source/>J. Neurosci
<volume>27</volume>,
<fpage>9817</fpage>–<lpage>9823</lpage>.<pub-id pub-id-type="pmid">17855595</pub-id></mixed-citation>
</ref>
<ref id="R21">
<mixed-citation publication-type="journal"><name><surname>Gottschalk</surname><given-names>MG</given-names></name>, <name><surname>Leussis</surname><given-names>MP</given-names></name>, <name><surname>Ruland</surname><given-names>T</given-names></name>, <name><surname>Gjeluci</surname><given-names>K</given-names></name>, <name><surname>Petryshen</surname><given-names>TL</given-names></name>, and <name><surname>Bahn</surname><given-names>S</given-names></name> (<year>2017</year>). <article-title>Lithium reverses behavioral and
axonal transport-related changes associated with ANK3 bipolar disorder gene
disruption</article-title>. <source/>Eur. Neuropsychopharmacol
<volume>27</volume>,
<fpage>274</fpage>–<lpage>288</lpage>.<pub-id pub-id-type="pmid">28109561</pub-id></mixed-citation>
</ref>
<ref id="R22">
<mixed-citation publication-type="journal"><name><surname>Guedes-Dias</surname><given-names>P</given-names></name>, <name><surname>Nirschl</surname><given-names>JJ</given-names></name>, <name><surname>Abreu</surname><given-names>N</given-names></name>, <name><surname>Tokito</surname><given-names>MK</given-names></name>, <name><surname>Janke</surname><given-names>C</given-names></name>, <name><surname>Magiera</surname><given-names>MM</given-names></name>, and <name><surname>Holzbaur</surname><given-names>ELF</given-names></name> (<year>2019</year>). <article-title>Kinesin-3 responds to local
microtubule dynamics to target synaptic cargo delivery to the
presynapse</article-title>. <source/>Curr. Biol
<volume>29</volume>,
<fpage>268</fpage>–<lpage>282.e8</lpage>.<pub-id pub-id-type="pmid">30612907</pub-id></mixed-citation>
</ref>
<ref id="R23">
<mixed-citation publication-type="journal"><name><surname>Harrington</surname><given-names>AJ</given-names></name>, <name><surname>Raissi</surname><given-names>A</given-names></name>, <name><surname>Rajkovich</surname><given-names>K</given-names></name>, <name><surname>Berto</surname><given-names>S</given-names></name>, <name><surname>Kumar</surname><given-names>J</given-names></name>, <name><surname>Molinaro</surname><given-names>G</given-names></name>, <name><surname>Raduazzo</surname><given-names>J</given-names></name>, <name><surname>Guo</surname><given-names>Y</given-names></name>, <name><surname>Loerwald</surname><given-names>K</given-names></name>, <name><surname>Konopka</surname><given-names>G</given-names></name>, <etal></etal> (<year>2016</year>). <article-title>MEF2C regulates cortical
inhibitory and excitatory synapses and behaviors relevant to
neurodevelopmental disorders</article-title>. <source/>eLife
<volume>5</volume>, <fpage>e20059</fpage>.<pub-id pub-id-type="pmid">27779093</pub-id></mixed-citation>
</ref>
<ref id="R24">
<mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>KP</given-names></name>, <name><surname>Akbergenova</surname><given-names>Y</given-names></name>, <name><surname>Cho</surname><given-names>RW</given-names></name>, <name><surname>Baas-Thomas</surname><given-names>MS</given-names></name>, and <name><surname>Littleton</surname><given-names>JT</given-names></name> (<year>2016</year>). <article-title>Shank modulates postsynaptic Wnt
signaling to regulate synaptic development</article-title>. <source/>J.
Neurosci
<volume>36</volume>,
<fpage>5820</fpage>–<lpage>5832</lpage>.<pub-id pub-id-type="pmid">27225771</pub-id></mixed-citation>
</ref>
<ref id="R25">
<mixed-citation publication-type="journal"><name><surname>Hevner</surname><given-names>RF</given-names></name>, <name><surname>Shi</surname><given-names>L</given-names></name>, <name><surname>Justice</surname><given-names>N</given-names></name>, <name><surname>Hsueh</surname><given-names>Y</given-names></name>, <name><surname>Sheng</surname><given-names>M</given-names></name>, <name><surname>Smiga</surname><given-names>S</given-names></name>, <name><surname>Bulfone</surname><given-names>A</given-names></name>, <name><surname>Goffinet</surname><given-names>AM</given-names></name>, <name><surname>Campagnoni</surname><given-names>AT</given-names></name>, and <name><surname>Rubenstein</surname><given-names>JLR</given-names></name> (<year>2001</year>). <article-title>Tbr1 regulates differentiation of
the preplate and layer 6</article-title>. <source/>Neuron
<volume>29</volume>,
<fpage>353</fpage>–<lpage>366</lpage>.<pub-id pub-id-type="pmid">11239428</pub-id></mixed-citation>
</ref>
<ref id="R26">
<mixed-citation publication-type="journal"><name><surname>Hevner</surname><given-names>RF</given-names></name>, <name><surname>Neogi</surname><given-names>T</given-names></name>, <name><surname>Englund</surname><given-names>C</given-names></name>, <name><surname>Daza</surname><given-names>RAM</given-names></name>, and <name><surname>Fink</surname><given-names>A</given-names></name> (<year>2003</year>). <article-title>Cajal-Retzius cells in the mouse:
transcription factors, neurotransmitters, and birthdays suggest a pallial
origin</article-title>. <source/>Brain Res. Dev. Brain Res
<volume>141</volume>,
<fpage>39</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">12644247</pub-id></mixed-citation>
</ref>
<ref id="R27">
<mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>T-N</given-names></name>, <name><surname>Chuang</surname><given-names>H-C</given-names></name>, <name><surname>Chou</surname><given-names>W-H</given-names></name>, <name><surname>Chen</surname><given-names>C-Y</given-names></name>, <name><surname>Wang</surname><given-names>H-F</given-names></name>, <name><surname>Chou</surname><given-names>S-J</given-names></name>, and <name><surname>Hsueh</surname><given-names>Y-P</given-names></name> (<year>2014</year>). <article-title><italic>Tbr1</italic>
haploinsufficiency impairs amygdalar axonal projections and results in
cognitive abnormality</article-title>. <source/>Nat. Neurosci
<volume>17</volume>,
<fpage>240</fpage>–<lpage>247</lpage>.<pub-id pub-id-type="pmid">24441682</pub-id></mixed-citation>
</ref>
<ref id="R28">
<mixed-citation publication-type="journal"><name><surname>Lallemend</surname><given-names>F</given-names></name>, <name><surname>Sterzenbach</surname><given-names>U</given-names></name>, <name><surname>Hadjab-Lallemend</surname><given-names>S</given-names></name>, <name><surname>Aquino</surname><given-names>JB</given-names></name>, <name><surname>Castelo-Branco</surname><given-names>G</given-names></name>, <name><surname>Sinha</surname><given-names>I</given-names></name>, <name><surname>Villaescusa</surname><given-names>JC</given-names></name>, <name><surname>Levanon</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Franck</surname><given-names>MCM</given-names></name>, <etal></etal> (<year>2012</year>). <article-title>Positional differences of
axon growth rates between sensory neurons encoded by Runx3</article-title>.
<source/>EMBO J. <volume>31</volume>,
<fpage>3718</fpage>–<lpage>3729</lpage>.<pub-id pub-id-type="pmid">22903063</pub-id></mixed-citation>
</ref>
<ref id="R29">
<mixed-citation publication-type="journal"><name><surname>Lenox</surname><given-names>RH</given-names></name>, and <name><surname>Wang</surname><given-names>L</given-names></name> (<year>2003</year>). <article-title>Molecular basis of lithium action:
integration of lithium-responsive signaling and gene expression
networks</article-title>. <source/>Mol. Psychiatry
<volume>8</volume>,
<fpage>135</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">12610644</pub-id></mixed-citation>
</ref>
<ref id="R30">
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L-B</given-names></name>, <name><surname>Lei</surname><given-names>H</given-names></name>, <name><surname>Arey</surname><given-names>RN</given-names></name>, <name><surname>Li</surname><given-names>P</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Murphy</surname><given-names>CT</given-names></name>, <name><surname>Xu</surname><given-names>XZS</given-names></name>, and <name><surname>Shen</surname><given-names>K</given-names></name> (<year>2016</year>). <article-title>The neuronal kinesin UNC-104/KIF1A
is a key regulator of synaptic aging and insulin signaling-regulated
memory</article-title>. <source/>Curr. Biol
<volume>26</volume>,
<fpage>605</fpage>–<lpage>615</lpage>.<pub-id pub-id-type="pmid">26877087</pub-id></mixed-citation>
</ref>
<ref id="R31">
<mixed-citation publication-type="journal"><name><surname>Madisen</surname><given-names>L</given-names></name>, <name><surname>Zwingman</surname><given-names>TA</given-names></name>, <name><surname>Sunkin</surname><given-names>SM</given-names></name>, <name><surname>Oh</surname><given-names>SW</given-names></name>, <name><surname>Zariwala</surname><given-names>HA</given-names></name>, <name><surname>Gu</surname><given-names>H</given-names></name>, <name><surname>Ng</surname><given-names>LL</given-names></name>, <name><surname>Palmiter</surname><given-names>RD</given-names></name>, <name><surname>Hawrylycz</surname><given-names>MJ</given-names></name>, <name><surname>Jones</surname><given-names>AR</given-names></name>, <etal></etal> (<year>2010</year>). <article-title>A robust and
high-throughput Cre reporting and characterization system for the whole
mouse brain</article-title>. <source/>Nat. Neurosci
<volume>13</volume>,
<fpage>133</fpage>–<lpage>140</lpage>.<pub-id pub-id-type="pmid">20023653</pub-id></mixed-citation>
</ref>
<ref id="R32">
<mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>P-M</given-names></name>, <name><surname>Stanley</surname><given-names>RE</given-names></name>, <name><surname>Ross</surname><given-names>AP</given-names></name>, <name><surname>Freitas</surname><given-names>AE</given-names></name>, <name><surname>Moyer</surname><given-names>CE</given-names></name>, <name><surname>Brumback</surname><given-names>AC</given-names></name>, <name><surname>lafrati</surname><given-names>J</given-names></name>, <name><surname>Stapornwongkul</surname><given-names>KS</given-names></name>, <name><surname>Dominguez</surname><given-names>S</given-names></name>, <name><surname>Kivimäe</surname><given-names>S</given-names></name>, <etal></etal> (<year>2018</year>). <article-title>DIXDC1 contributes to
psychiatric susceptibility by regulating dendritic spine and glutamatergic
synapse density via GSK3 and Wnt/β-catenin signaling</article-title>.
<source/>Mol. Psychiatry
<volume>23</volume>,
<fpage>467</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">27752079</pub-id></mixed-citation>
</ref>
<ref id="R33">
<mixed-citation publication-type="journal"><name><surname>McKenna</surname><given-names>WL</given-names></name>, <name><surname>Betancourt</surname><given-names>J</given-names></name>, <name><surname>Larkin</surname><given-names>KA</given-names></name>, <name><surname>Abrams</surname><given-names>B</given-names></name>, <name><surname>Guo</surname><given-names>C</given-names></name>, <name><surname>Rubenstein</surname><given-names>JLR</given-names></name>, and <name><surname>Chen</surname><given-names>B</given-names></name> (<year>2011</year>). <article-title><italic>Tbr1</italic> and
<italic>Fezf2</italic> regulate alternate corticofugal neuronal
identities during neocortical development</article-title>. <source/>J.
Neurosci
<volume>31</volume>,
<fpage>549</fpage>–<lpage>564</lpage>.<pub-id pub-id-type="pmid">21228164</pub-id></mixed-citation>
</ref>
<ref id="R34">
<mixed-citation publication-type="journal"><name><surname>Morfini</surname><given-names>G</given-names></name>, <name><surname>Szebenyi</surname><given-names>G</given-names></name>, <name><surname>Elluru</surname><given-names>R</given-names></name>, <name><surname>Ratner</surname><given-names>N</given-names></name>, and <name><surname>Brady</surname><given-names>ST</given-names></name> (<year>2002</year>). <article-title>Glycogen synthase kinase 3
phosphorylates kinesin light chains and negatively regulates kinesin-based
motility</article-title>. <source/>EMBO J. <volume>21</volume>,
<fpage>281</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">11823421</pub-id></mixed-citation>
</ref>
<ref id="R35">
<mixed-citation publication-type="journal"><name><surname>Ohba</surname><given-names>C</given-names></name>, <name><surname>Haginoya</surname><given-names>K</given-names></name>, <name><surname>Osaka</surname><given-names>H</given-names></name>, <name><surname>Kubota</surname><given-names>K</given-names></name>, <name><surname>Ishiyama</surname><given-names>A</given-names></name>, <name><surname>Hiraide</surname><given-names>T</given-names></name>, <name><surname>Komaki</surname><given-names>H</given-names></name>, <name><surname>Sasaki</surname><given-names>M</given-names></name>, <name><surname>Miyatake</surname><given-names>S</given-names></name>, <name><surname>Nakashima</surname><given-names>M</given-names></name>, <etal></etal> (<year>2015</year>). <article-title>De novo KIF1A mutations
cause intellectual deficit, cerebellar atrophy, lower limb spasticity and
visual disturbance</article-title>. <source/>J. Hum. Genet
<volume>60</volume>,
<fpage>739</fpage>–<lpage>742</lpage>.<pub-id pub-id-type="pmid">26354034</pub-id></mixed-citation>
</ref>
<ref id="R36">
<mixed-citation publication-type="journal"><name><surname>Paspalas</surname><given-names>CD</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, and <name><surname>Arnsten</surname><given-names>AFT</given-names></name> (<year>2013</year>). <article-title>Constellation of HCN channels and
cAMP regulating proteins in dendritic spines of the primate prefrontal
cortex: potential substrate for working memory deficits in
schizophrenia</article-title>. <source/>Cereb. Cortex
<volume>23</volume>,
<fpage>1643</fpage>–<lpage>1654</lpage>.<pub-id pub-id-type="pmid">22693343</pub-id></mixed-citation>
</ref>
<ref id="R37">
<mixed-citation publication-type="journal"><name><surname>Pennings</surname><given-names>M</given-names></name>, <name><surname>Schouten</surname><given-names>MI</given-names></name>, <name><surname>van Gaalen</surname><given-names>J</given-names></name>, <name><surname>Meijer</surname><given-names>RPP</given-names></name>, <name><surname>de Bot</surname><given-names>ST</given-names></name>, <name><surname>Kriek</surname><given-names>M</given-names></name>, <name><surname>Saris</surname><given-names>CGJ</given-names></name>, <name><surname>van den Berg</surname><given-names>LH</given-names></name>, <name><surname>van Es</surname><given-names>MA</given-names></name>, <name><surname>Zuidgeest</surname><given-names>DMH</given-names></name>, <etal></etal> (<year>2020</year>). <article-title>KIF1A variants are a
frequent cause of autosomal dominant hereditary spastic
paraplegia</article-title>. <source/>Eur. J. Hum. Genet
<volume>28</volume>,
<fpage>40</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">31488895</pub-id></mixed-citation>
</ref>
<ref id="R38">
<mixed-citation publication-type="journal"><name><surname>Rosso</surname><given-names>SB</given-names></name>, <name><surname>Sussman</surname><given-names>D</given-names></name>, <name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2005</year>). <article-title>Wnt signaling through Dishevelled,
Rac and JNK regulates dendritic development</article-title>. <source/>Nat.
Neurosci. <volume>8</volume>,
<fpage>34</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">15608632</pub-id></mixed-citation>
</ref>
<ref id="R39">
<mixed-citation publication-type="journal"><name><surname>Rosti</surname><given-names>RO</given-names></name>, <name><surname>Sadek</surname><given-names>AA</given-names></name>, <name><surname>Vaux</surname><given-names>KK</given-names></name>, and <name><surname>Gleeson</surname><given-names>JG</given-names></name> (<year>2014</year>). <article-title>The genetic landscape of autism
spectrum disorders</article-title>. <source/>Dev. Med. Child Neurol
<volume>56</volume>,
<fpage>12</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">24116704</pub-id></mixed-citation>
</ref>
<ref id="R40">
<mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Willsey</surname><given-names>AJ</given-names></name>, <name><surname>Ercan-Sencicek</surname><given-names>AG</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Cicek</surname><given-names>AE</given-names></name>, <name><surname>Murtha</surname><given-names>MT</given-names></name>, <name><surname>Bal</surname><given-names>VH</given-names></name>, <name><surname>Bishop</surname><given-names>SL</given-names></name>, <name><surname>Dong</surname><given-names>S</given-names></name>, <etal></etal>; <collab>Autism Sequencing Consortium</collab>
(<year>2015</year>). <article-title>Insights into autism spectrum disorder
genomic architecture and biology from 71 risk loci</article-title>.
<source/>Neuron
<volume>87</volume>,
<fpage>1215</fpage>–<lpage>1233</lpage>.<pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="R41">
<mixed-citation publication-type="journal"><name><surname>Serret</surname><given-names>S</given-names></name>, <name><surname>Thümmler</surname><given-names>S</given-names></name>, <name><surname>Dor</surname><given-names>E</given-names></name>, <name><surname>Vesperini</surname><given-names>S</given-names></name>, <name><surname>Santos</surname><given-names>A</given-names></name>, and <name><surname>Askenazy</surname><given-names>F</given-names></name> (<year>2015</year>). <article-title>Lithium as a rescue therapy for
regression and catatonia features in two SHANK3 patients with autism
spectrum disorder: case reports</article-title>. <source/>BMC
Psychiatry
<volume>15</volume>, <fpage>107</fpage>.<pub-id pub-id-type="pmid">25947967</pub-id></mixed-citation>
</ref>
<ref id="R42">
<mixed-citation publication-type="journal"><name><surname>Sestan</surname><given-names>N</given-names></name>, and <name><surname>State</surname><given-names>MW</given-names></name> (<year>2018</year>). <article-title>Lost in translation: traversing the
complex path from genomics to therapeutics in autism spectrum
disorder</article-title>. <source/>Neuron
<volume>100</volume>,
<fpage>406</fpage>–<lpage>423</lpage>.<pub-id pub-id-type="pmid">30359605</pub-id></mixed-citation>
</ref>
<ref id="R43">
<mixed-citation publication-type="journal"><name><surname>Shepherd</surname><given-names>GMG</given-names></name> (<year>2013</year>). <article-title>Corticostriatal connectivity and its
role in disease</article-title>. <source/>Nat. Rev. Neurosci
<volume>14</volume>,
<fpage>278</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">23511908</pub-id></mixed-citation>
</ref>
<ref id="R44">
<mixed-citation publication-type="journal"><name><surname>Stamatakou</surname><given-names>E</given-names></name>, and <name><surname>Salinas</surname><given-names>PC</given-names></name> (<year>2014</year>). <article-title>Postsynaptic assembly: a role for
Wnt signaling</article-title>. <source/>Dev. Neurobiol
<volume>74</volume>,
<fpage>818</fpage>–<lpage>827</lpage>.<pub-id pub-id-type="pmid">24105999</pub-id></mixed-citation>
</ref>
<ref id="R45">
<mixed-citation publication-type="journal"><name><surname>State</surname><given-names>MW</given-names></name>, and <name><surname>Šestan</surname><given-names>N</given-names></name> (<year>2012</year>). <article-title>Neuroscience. The emerging biology
of autism spectrum disorders</article-title>. <source/>Science
<volume>337</volume>,
<fpage>1301</fpage>–<lpage>1303</lpage>.<pub-id pub-id-type="pmid">22984058</pub-id></mixed-citation>
</ref>
<ref id="R46">
<mixed-citation publication-type="journal"><name><surname>van Noort</surname><given-names>M</given-names></name>, <name><surname>Meeldijk</surname><given-names>J</given-names></name>, <name><surname>van der Zee</surname><given-names>R</given-names></name>, <name><surname>Destree</surname><given-names>O</given-names></name>, and <name><surname>Clevers</surname><given-names>H</given-names></name> (<year>2002</year>). <article-title>Wnt signaling controls the
phosphorylation status of β-catenin</article-title>. <source/>J. Biol.
Chem
<volume>277</volume>,
<fpage>17901</fpage>–<lpage>17905</lpage>.<pub-id pub-id-type="pmid">11834740</pub-id></mixed-citation>
</ref>
<ref id="R47">
<mixed-citation publication-type="journal"><name><surname>Vogt</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>P-R</given-names></name>, <name><surname>Sorrells</surname><given-names>SF</given-names></name>, <name><surname>Arnold</surname><given-names>C</given-names></name>, <name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name>, and <name><surname>Rubenstein</surname><given-names>JLR</given-names></name> (<year>2015</year>). <article-title>Viral-mediated labeling and
transplantation of medial ganglionic eminence (MGE) cells for in vivo
studies</article-title>. <source/>J. Vis. Exp
<volume>98</volume>, <fpage>52740</fpage>.</mixed-citation>
</ref>
<ref id="R48">
<mixed-citation publication-type="journal"><name><surname>Willsey</surname><given-names>AJ</given-names></name>, <name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Dong</surname><given-names>S</given-names></name>, <name><surname>Tebbenkamp</surname><given-names>AT</given-names></name>, <name><surname>Muhle</surname><given-names>RA</given-names></name>, <name><surname>Reilly</surname><given-names>SK</given-names></name>, <name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>Fertuzinhos</surname><given-names>S</given-names></name>, <name><surname>Miller</surname><given-names>JA</given-names></name>, <etal></etal> (<year>2013</year>). <article-title>Coexpression networks
implicate human midfetal deep cortical projection neurons in the
pathogenesis of autism</article-title>. <source/>Cell
<volume>155</volume>,
<fpage>997</fpage>–<lpage>1007</lpage>.<pub-id pub-id-type="pmid">24267886</pub-id></mixed-citation>
</ref>
<ref id="R49">
<mixed-citation publication-type="journal"><name><surname>Yi</surname><given-names>F</given-names></name>, <name><surname>Danko</surname><given-names>T</given-names></name>, <name><surname>Botelho</surname><given-names>SC</given-names></name>, <name><surname>Patzke</surname><given-names>C</given-names></name>, <name><surname>Pak</surname><given-names>C</given-names></name>, <name><surname>Wernig</surname><given-names>M</given-names></name>, and <name><surname>Südhof</surname><given-names>TC</given-names></name> (<year>2016</year>). <article-title>Autism-associated SHANK3
haploinsufficiency causes I<sub>h</sub> channelopathy in human
neurons</article-title>. <source/>Science
<volume>352</volume>, <fpage>aaf2669</fpage>.<pub-id pub-id-type="pmid">26966193</pub-id></mixed-citation>
</ref>
<ref id="R50">
<mixed-citation publication-type="journal"><name><surname>Yoshikawa</surname><given-names>K</given-names></name>, <name><surname>Kuwahara</surname><given-names>M</given-names></name>, <name><surname>Saigoh</surname><given-names>K</given-names></name>, <name><surname>Ishiura</surname><given-names>H</given-names></name>, <name><surname>Yamagishi</surname><given-names>Y</given-names></name>, <name><surname>Hamano</surname><given-names>Y</given-names></name>, <name><surname>Samukawa</surname><given-names>M</given-names></name>, <name><surname>Suzuki</surname><given-names>H</given-names></name>, <name><surname>Hirano</surname><given-names>M</given-names></name>, <name><surname>Mitsui</surname><given-names>Y</given-names></name>, <etal></etal> (<year>2018</year>). <article-title>The novel de novo mutation
of KIF1A gene as the cause for spastic paraplegia 30 in a Japanese
case</article-title>. <source/>eNeurologicalSci
<volume>14</volume>,
<fpage>34</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">30582020</pub-id></mixed-citation>
</ref>
<ref id="R51">
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>YV</given-names></name>, <name><surname>Hannan</surname><given-names>SB</given-names></name>, <name><surname>Kern</surname><given-names>JV</given-names></name>, <name><surname>Stanchev</surname><given-names>DT</given-names></name>, <name><surname>Koç</surname><given-names>B</given-names></name>, <name><surname>Jahn</surname><given-names>TR</given-names></name>, and <name><surname>Rasse</surname><given-names>TM</given-names></name> (<year>2017</year>). <article-title>The KIF1A homolog Unc-104 is
important for spontaneous release, postsynaptic density maturation and
perisynaptic scaffold organization</article-title>. <source/>Sci.
Rep
<volume>7</volume>, <fpage>38172</fpage>.<pub-id pub-id-type="pmid">28344334</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<title><italic>Tbr1</italic> Regulates Genes that Are Implicated in Controlling the
Development of Axons, Synapses, and Dendrites in Layer 5 Pyramidal Neurons of
the mPFC</title>
<p id="P100">(A) <italic>t</italic>-distributed stochastic neighbor embedding
(<italic>t</italic>-SNE) plot displaying 11,070 single neuronal cells from
<italic>Tbr1</italic><sup><italic>layer5</italic></sup> WT (red) and from
<italic>Tbr1<sup>layer5</sup></italic> heterozygous (HET; green), and
<italic>Tbr1<sup>layer5</sup></italic> homozygous (NULL; blue) CKOs.
t-SNE was performed after quality control and removal of non-neuronal cell
subtypes.</p>
<p id="P101">(B) Heatmap of DEX genes (FDR &lt; 0.05) shared between both
genotypes (x axis, n = 218) over a randomly selected 1,000 cells from each
genotype (y axis, n = 3,000). Genes are ordered by hierarchal clustering within
direction of regulation grouping, and the <italic>Z</italic> score of normalized
gene expression data is shown. The genotype for each cell is depicted at the
top, and genes with membership in selected enriched GO categories are
highlighted at the right.</p>
<p id="P102">See also <xref ref-type="supplementary-material" rid="SD5">Figures
S1</xref>-<xref ref-type="supplementary-material" rid="SD5">S3</xref>.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0002"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<title><italic>Tbr1</italic> Regulates Expression in the mPFC</title>
<p id="P103"><italic>In situ</italic> hybridization defines rostral cortical
lamination and validates the changes in scRNA-seq expression levels.</p>
<p id="P104">(i) PFC lamination. Prefrontal cortical lamination was defined using
ISH on coronal sections of neonatal mPFC in WT mice at P3.</p>
<p id="P105">(A–O) ISH was performed on rostral, medial, and caudal areas,
respectively, using (A–C) <italic>Cux2</italic> (layers 2–4);
(D–F) <italic>Rorb</italic> (layer 4); (G–I) <italic>Etv1</italic>
(layer 5); (J–L) <italic>Tbr1</italic> (layers2/3, 5, and 6); and
(M–O) <italic>Nr4a2</italic> (subplate or layer 6b). Cortical layers in
the medial and dorsal regions are labeled. MO, medial orbital cortex; PrL,
prelimbic cortex; FrA, frontal association cortex; OC, orbital cortex; Cg1,
cingulate cortex area 1; M, motor cortex; S1, primary somatosensory cortex; IC,
insular cortex; II-IV, layers 2–4; V, layer 5; VI, layer 6; VIb,
subplate. Scale bar, 300 μm.</p>
<p id="P106">(ii) scRNA-seq validation. ISH confirms the changes in the
transcriptome changes from DEX analysis of scRNA-seq in
<italic>Tbr1<sup>layer5</sup></italic> homozygous mutants.</p>
<p id="P107">(P–W) The expression of <italic>Mgst3</italic> (P and Q) and
<italic>Calm2</italic> (R and S) are increased in layer 5<sup>upper</sup> (Q
and S). <italic>Tbr1<sup>layer5</sup></italic> mutants exhibit reduced
expression of <italic>Wnt7b</italic> (T and U) and <italic>Kif1a</italic> (V and
W) in layer 5 of the mPFC at P3. Only one hemisphere is shown from the ISH
images from WT and <italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs, which
are presented as mirror images, to aid in evaluating the changes in laminar gene
expression. Color code: downregulated (red) and upregulated (green). Red box
shown in (P) and (Q) indicates the region that was dissected for scRNA-seq
analyses. Cortical layers 2–4, 5<sup>upper</sup>, 5<sup>lower</sup>, 6,
and 6b (subplate) are labeled. Scale bar, 100 μm.</p>
<p id="P108">See also <xref ref-type="supplementary-material" rid="SD5">Figure
S3</xref>.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0003"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<title><italic>Tbr1</italic> Mutants Have Reduced Excitatory and Inhibitory Synaptic
Densities at P56</title>
<p id="P109">IF was used to detect excitatory (i) and inhibitory (ii) synapses onto
dendrites of (1) the mPFC of <italic>Tbr1<sup>wild-type</sup></italic>
(<italic>Rbp4-cre</italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>;
red), <italic>Tbr1<sup>layer5</sup></italic> heterozygous
(<italic>Tbr1</italic><sup><italic>f</italic>/+</sup>∷<italic><italic>Rbp4-cre</italic></italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>;
green), and <italic>Tbr1<sup>layer5</sup></italic> homozygous
(<italic>Tbr1<sup>f/f</sup></italic>∷<italic><italic>Rbp4-cre</italic></italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>;
blue) mutants (n = 30 dendrites), and (2) dendrites of layer 5 neurons from the
mPFC of <italic>Tbr1<sup>wild-type</sup></italic>,
<italic>Tbr1</italic><sup>+/−</sup> and layer 6 neurons from the SSCx
of <italic>Tbr1<sup>wild-type</sup></italic>,
<italic>Tbr1</italic><sup>+/−</sup> (n = 15 dendrites).</p>
<p id="P110">(A–C′) Excitatory synapses were identified by
colocalization of VGLUT1<sup>+</sup> boutons and PSD95<sup>+</sup> clusters on
dendrites of layer 5 pyramidal neurons at P56 (A′ and C′).</p>
<p id="P111">(A) Quantification of excitatory synaptic density.</p>
<p id="P112">(B) Quantification of the sEPSC frequency from layer 5 neurons at P56
(n = 6/6/6, WT/heterozygous/homozygous cells from two different animals per
genotype).</p>
<p id="P113">(B′) Sample traces of sEPSC recordings at P56.</p>
<p id="P114">(C) Quantification of excitatory synaptic density of
<italic>Tbr1</italic><sup>+/−</sup> mutants in cortical layers 5 and
6 at P56.</p>
<p id="P115">(D–F′) Inhibitory synapses were identified by
co-localizing VGAT<sup>+</sup> boutons and Gephyrin<sup>+</sup> clusters
(D′ and F′).</p>
<p id="P116">(D) Quantification of inhibitory synaptic density on dendrites of layer
5 pyramidal neurons at P56.</p>
<p id="P117">(E) Quantification of the sIPSC frequency from layer 5 neurons at P56
(n = 7/7/7, WT/heterozygous/homozygous cells from two different animals per
genotype). (E′) Sample traces of sIPSC recordings at P56.</p>
<p id="P118">(F) Quantification of inhibitory synapse numbers on dendrites of layer
5 and 6 pyramidal neurons of <italic>Tbr1</italic><sup>+/−</sup> mutants
at P56.</p>
<p id="P119">(iii) <italic>In vitro</italic> rescue assay was conducted by
transfecting <italic>Kif1a</italic>, <italic>Mef2c</italic>,
<italic>Rac3</italic>, and <italic>Syt4</italic> expression vectors into P0
primary cortical culture from <italic>Tbr1<sup>wild-type</sup></italic> (red)
and <italic>Tbr1<sup>layer5</sup></italic> CKOs (blue) (n = 3 biological
replicates).</p>
<p id="P120">(G–H′) Excitatory (G) and inhibitory (H) synaptic density
was analyzed 14 days post-transfection. Quantification of excitatory (G′)
and inhibitory (H′) synaptic density <italic>in vitro</italic> is
indicated. Red box indicates a successful rescue of synaptic density. Two-way
ANOVA was used for the statistical analysis of the control, heterozygote, and
null. Two-tailed t test with Tukey correction was used for pairwise comparisons.
Floating bar graphs represent the minimum-to maximum (min-max) distribution of
synaptic density and/or EPSC/IPSC frequency measured from each genotype.
Horizontal line in each box denotes the average distribution. Average
distribution is numerically indicated in each box (**p &lt; 0.01; ***p
&lt; 0.001; ****p &lt; 0.0001). ns, not significant.</p>
<p id="P121">See also <xref ref-type="supplementary-material" rid="SD5">Figures
S4</xref> and <xref ref-type="supplementary-material" rid="SD5">S5</xref>.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0004"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<title>LiCl Rescues Dendritic Spine Density of
<italic>Tbr1<sup>layer5</sup></italic> CKOs</title>
<p id="P122">(A–L″) In (A)–(L),
<italic><italic>Rbp4-cre</italic></italic>∷<italic>tdTomato</italic><sup><italic>f</italic>/+</sup>
allele was used to label the dendrites of layer 5 neurons. Imaris software was
used to analyze the dendritic spine density on the apical dendrites of
<italic>Tbr1<sup>layer5</sup></italic> WT and
<italic>Tbr1<sup>layer5</sup></italic> CKO neurons located within layers
2–4 of the mPFC (A′–L′). Changes in the dendritic
spine density of layer 5 neurons were examined at P5 (A–D), P21
(E–G), and P60 (H–L). (A″–L″) Merged
images.</p>
<p id="P123">(M) Quantification of dendritic spine density at P5 and P21. Spine
density was improved 24 hr after LiCl treatment at P5 in (C) and (D) and P60 in
(K) and (L), compared to the saline-injected control animals in (A) and (B) and
in (H) and (J).</p>
<p id="P124">(N) Quantification of mature dendritic spines of
<italic>Tbr1<sup>layer5</sup></italic> WT and mutant neurons at P60, 24
h after injection with saline (control) or LiCl. Floating bar graphs represent
min-max distribution of the dendritic spine density of layer 5 neurons within
layers 2–4 of the mPFC. Horizontal line in each box denotes the average
spine density. Average mature dendritic spine density is numerically indicated
in each box.</p>
<p id="P125">****p &lt; 0.0001. ns, not significant. Scale bar, 8 μm.</p>
<p id="P126">See also <xref ref-type="supplementary-material" rid="SD5">Figure
S6</xref>.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0005"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<title>LiCl Treatment Restores Synapse Numbers and Corticothalamic Axonal
Arborization of <italic>Tbr1</italic> Mutant Mice</title>
<p id="P127">Excitatory (i) and inhibitory (ii) synaptic densities were quantified
at P60 from: (1) apical dendrites of <italic>Tbr1<sup>layer5CKO</sup></italic>
and <italic>Tbr1<sup>layer6CKO</sup></italic> mice 4 weeks after P30 injection
with saline or LiCl (n = 15 dendrites) and (2) dendrites of layer 5 neurons from
the mPFC of <italic>Tbr1<sup>wiid-type</sup></italic>,
<italic>Tbr1</italic><sup>+/−</sup> and layer 6 neurons from the SSCx
of <italic>Tbr1<sup>wild-type</sup></italic>,
<italic>Tbr1</italic><sup>+/−</sup> mice 24 h after injection with
saline or LiCl at P59 (n = 15 dendrites).</p>
<p id="P128">(A and B) Excitatory synapses were quantified from (A) layer 5 neurons
of the mPFC of <italic>Tbr1<sup>wild-type</sup></italic> (green) and
<italic>Tbr1<sup>layer5CKO</sup></italic> (orange) mice and (B) layer 6
neurons from the SSCx of <italic>Tbr1<sup>wild-type</sup></italic> (red) and
<italic>Tbr1<sup>layer6CKO</sup></italic> (blue) mice at P60, 4 weeks
after saline and/or LiCl was administered.</p>
<p id="P129">(C and D) Quantification of excitatory synaptic density of (C) layer 5
neurons of the mPFC of <italic>Tbr1<sup>wild-type</sup></italic> (green) and
<italic>Tbr1</italic><sup>+/−</sup> (orange) mice and (D) layer 6
neurons from the SSCx of <italic>Tbr1<sup>wild-type</sup></italic> (red) and
<italic>Tbr1</italic><sup>+/−</sup> (blue) mice at P60, 24 h after
injection with saline or LiCl.</p>
<p id="P130">(E and F) Inhibitory synapses were quantified from (E) the mPFC of
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer5CKO</sup></italic> and (F) the SSCx of
<italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1<sup>layer6CKO</sup></italic> mice 4 weeks after saline
and/or LiCl was administered at P30.</p>
<p id="P131">(G and H) Inhibitory synapses were quantified from (G) layer 5 neurons
of the mPFC of <italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1</italic><sup>+/−</sup> and (H) layer 6 neurons of the
SSCx of <italic>Tbr1<sup>wild-type</sup></italic> and
<italic>Tbr1</italic><sup>+/−</sup> mice at P60 24 h after injection
with saline or LiCl. Floating bar graphs represent the min-max distribution of
all excitatory and inhibitory synapse numbers measured from each genotype.
Horizontal line in each box denotes the average distribution. Average
distribution is numerically indicated in each box. Two-tailed t test with Tukey
correction was used for pairwise comparisons (***p &lt; 0.001; ****p
&lt; 0.0001). ns, not significant.</p>
<p id="P132">(I–P) In section iii, corticothalamic axonal arborization in the
thalamus is indicated by tdTomato’s endogenous fluorescence of
<italic>Tbr1<sup>layer6</sup></italic> WT (I–L) and
<italic>Tbr1<sup>layer6</sup></italic> homozygous CKO (M–P) mice.
The monochrome tdTomato signal (white) is indicated from saline-injected (I and
M) mice, 24 h after LiCl injection (J and N), 24 h after GSK3β-inhibitor
injection (K and O), and 4 weeks after LiCl injection (L and P). White
arrowheads in (M) indicate thalamic regions that have reduced corticothalamic
axonal arborization in <italic>Tbr1<sup>layer6</sup></italic> CKO. Yellow
arrowheads in (N)–(P) correspond to improved corticothalamic axonal
arborization in <italic>Tbr1<sup>layer6</sup></italic> CKO at P60 following LiCl
treatment after 24 h (N), GSK3β-inhibitor (GSK3βi) treatment after
24 h (O), and LiCl treatment after 4 weeks (P). Yellow box depicts a high
magnification of the SSCx, demonstrating that LiCl and GSK3β-inhibitor
treatments did not rescue the layer 6 apical dendrite morphogenesis in
<italic>Tbr1<sup>layer6</sup></italic> CKOs. Thalamus, cortex (Cx), and
corticothalamic axons (CTAs) are labeled. Scale bars: white, 1 mm; blue, 50
μm.</p>
<p id="P133">(iv) Quantification of the tdTomato pixel intensity in the boxed
regions in (I) and (M) from saline-injected
<italic>Tbr1<sup>wild-type</sup></italic> (WT-Saline) and
<italic>Tbr1<sup>layer6</sup></italic> homozygous mutants (Null-Saline)
at P60. tdTomato signal intensity is improved in the thalamus of the
<italic>Tbr1<sup>layer6</sup></italic> homozygous CKO 24 h and 4 weeks
after treatment compared to treatment of
<italic>Tbr1<sup>wild-type</sup></italic> at 24 h and 4 weeks. Two-tailed t
test with Tukey correction was used for pairwise comparisons. Floating bar
graphs represent the min-max distribution of tdTomato pixel density measured
from region 1 of all genotypes and treatments. Horizontal line in each box
denotes the average distribution. Average distribution is numerically indicated
in each box (***p &lt; 0.001; ****p &lt; 0.0001).</p>
<p id="P134">See also <xref ref-type="supplementary-material" rid="SD5">Figures
S7</xref>, <xref ref-type="supplementary-material" rid="SD5">S8</xref>, and
<xref ref-type="supplementary-material" rid="SD5">S9</xref>.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0006"></graphic>
</fig>
<fig id="F6" orientation="portrait" position="float">
<label>Figure 6.</label>
<caption>
<title>LiCl Treatment Rescues Social Interaction Deficit of
<italic>Tbr1<sup>layer5</sup></italic> Mutants</title>
<p id="P135">(A) <italic>Tbr1<sup>layer5</sup></italic> homozygous CKOs (blue)
showed reduced social interaction with a juvenile mouse at P56–P80. LiCl
treatment of <italic>Tbr1<sup>layer5</sup></italic> CKOs rescued the social
deficit phenotype compared to the saline-treated mutants at P56–P80.</p>
<p id="P136">(B) LiCl treatment of <italic>Tbr1<sup>layer5</sup></italic> CKOs did
not affect the time spent engaged in novel object exploration compared to the
saline-injected control. Floating bar graphs represent the min-max distribution
of interaction measured from all genotypes and treatments. Horizontal line in
each box denotes the average distribution. Average distribution is numerically
indicated in each box.</p>
<p id="P137">Two-tailed t test with Tukey correction was used for pairwise
comparisons (*p &lt; 0.05).</p>
</caption>
<graphic xlink:href="nihms-1622004-f0007"></graphic>
</fig>
<fig id="F7" orientation="portrait" position="float">
<label>Figure 7.</label>
<caption>
<title>Model of How <italic>Tbr1</italic> Controls Spine Maturation and
Synaptogenesis through Promoting WNT Signaling: Links to ASD
Pathogenesis</title>
<p id="P138">Schematic representation of how <italic>Tbr1</italic> controls spine
maturation and synaptogenesis in cortical layers 5 and 6. <italic>Tbr1</italic>
regulates WNT signaling by promoting <italic>Wnt7b</italic> and
<italic>Ctnnb1</italic> and represses <italic>Gsk3β</italic>
expression. LiCl (blue) and GSK3β inhibitor (green) rescues
<italic>Tbr1</italic> phenotypes through stimulating WNT signaling by
inhibiting GSK3β activity. WNT inhibition of GSK3β results in
phosphorylation of MAP1A and MAP1B, which promotes microtubule assembly and
axonal outgrowth. <italic>Tbr1</italic> activates <italic>Kif1a</italic>, a
kinesin motor protein involved in synaptic vesicle trafficking. Furthermore,
<italic>Tbr1</italic> activates <italic>Foxp2</italic> and
<italic>Mef2c</italic> in layer 6 pyramidal neurons. <italic>Mef2c</italic>
promotes the development of excitatory synapses. Lastly, TBR1 promotes
expression of <italic>Cyp26b1</italic> in layer 6 pyramidal neurons, which
controls RA levels and impacts synaptic development. Asterisks indicate hcASD
(red, reduced in <italic>Tbr1</italic> mutants) and pASD (green, increased in
<italic>Tbr1</italic> mutants) genes that are involved in these pathways.
Cell membrane and nuclear membrane (blue) are indicated. Pathways unique to
layer 5 and layer 6 are shown in orange and yellow, respectively. Convergent
pathways between layers 5 and 6 are highlighted in blue.</p>
</caption>
<graphic xlink:href="nihms-1622004-f0008"></graphic>
</fig>
<table-wrap id="T1" orientation="portrait" position="float">
<caption>
<p id="P139">KEY RESOURCES TABLE</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">REAGENT or RESOURCE</th>
<th align="left" colspan="1" rowspan="1" valign="middle">SOURCE</th>
<th align="left" colspan="1" rowspan="1" valign="middle">IDENTIFIER</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Antibodies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rabbit anti-Vglutl polyclonal antibody</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic Systems</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 135303</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RRID: AB_887875</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse anti-PSD95 antibody</td>
<td align="left" colspan="1" rowspan="1" valign="top">NeuroMab (UC Davis)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 75-028</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RRID: AB_2307331</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rabbit anti-Vgat polyclonal antibody</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic Systems</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 131002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RRID: AB_887871</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse anti-Gephyrin polyclonal antibody</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic Systems</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 147011</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RRID: AB_887717</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Goat anti-Rabbit IgG Alexa Fluor 488</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thermofisher Scientific</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# A-11008</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RRID: AB_143165</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Goat anti-Mouse Alexa Fluor 647</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thermofisher Scientific</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# A32728</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">RRID:
AB_2633277</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Bacterial and Virus Strains</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">pLenti- CAG- Flex-Wnt7b-IRES-GFP</td>
<td align="left" colspan="1" rowspan="1" valign="top">This paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">pLenti-DlxI12b-Wnt7b-GFP</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">pLenti-DlxI12b-GFP</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">pLenti-CAG-Flex-IRES-GFP</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">This
Paper</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Chemicals, Peptides, and Recombinant Proteins</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sucrose</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# S5016</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sodium bicarbonate (NaHCO<sub>3</sub>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# S6014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Glucose</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# G5767</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Magnesium sulfate (MgSO<sub>4</sub>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 230391</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sodium phosphate monobasic monohydrate
(NaH<sub>2</sub>PO<sub>4</sub>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# P9638</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Potassium chloride (KCl)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# P9333</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Calcium chloride dehydrate
(CaCl<sub>2</sub>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 223506</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Magnesium chloride dexahydrate
(MgCl<sub>2</sub>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# M9272</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Potassium gluconate (KGluconate)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# P1847</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HEPES</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# H3375</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EGTA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# E4378</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adenosine 5′-triphosphate magnesium
salt (Mg-ATP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# A9187</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Guanosine 5′-triphosphate sodium salt
hydrate (Na<sub>3</sub>GTP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 51120</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cesium Methanesulfonate</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# C1426</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sodium Chloride (NaCl)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sigma Aldrich</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# S9888</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">QX314 chloride</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tocris</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 2313</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">ZD7288</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Tocris</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Cat#
1000</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Critical Commercial Assays</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bioanalyzer High Sensitivity DNA Kit</td>
<td align="left" colspan="1" rowspan="1" valign="top">Agilent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 5067-4626</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bioanalyzer RNA 6000 Nano Kit</td>
<td align="left" colspan="1" rowspan="1" valign="top">Agilent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 5067-1511</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chromium i7 Multiplex Kit,</td>
<td align="left" colspan="1" rowspan="1" valign="top">10X Genomics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 120262</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chromium Single Cell 3’ Chip Kit
v2</td>
<td align="left" colspan="1" rowspan="1" valign="top">10X Genomics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cat# 120236</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Chromium
Single Cell 3′ Library &amp; Gel Bead Kit v2</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">10X
Genomics</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Cat#
120237</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Deposited Data</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top"><italic>Tbr1</italic> P5 scRNA-seq Raw and Analyzed Data</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">This
paper</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146298">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146298</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Experimental Models: Cell Lines</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse primary cortical culture</td>
<td align="left" colspan="1" rowspan="1" valign="top">This paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">HEK293
cells</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Thermofisher
Scientific</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Cat#
R79007</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Experimental Models: Organisms/Strains</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse TBR1 conditional mutant</td>
<td align="left" colspan="1" rowspan="1" valign="top">This paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Mouse TBR1
constitutive mutant</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">This
paper</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Oligonucleotides</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping flox allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ND.for GAC ACA CAC CCT TCT TCA GTT TAC
AGC</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping flox allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ND.rev CAA GCC CGA CTG CCA ATG TTC TG</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping Ntsr1-cre allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ntsr1-cre.for GAC GCC ACG CCC CCC TTA</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping Ntsr1-cre allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ntsr1-cre.rev CGG CAA ACG GAC AGA AGC ATT</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping Rbp4-cre allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rbp4-cre.for GGG CGG CCT CGG TCC TC</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping Rbp4-cre allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rbp4-cre.rev CCC CAG AAA TGC CAG ATT ACG
TAT</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping tdTomato allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">tdTomato.for CTG TTC CTG TAC GGC ATG G</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping tdTomato allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">tdTomato.rev GGC ATT AAA GCA GCG TAT CC</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping constitutive allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LN.for CAT TCA GAG CGA CGC ATC AAA GC</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primer for genotyping constitutive allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">LN.rev CAA
GCC CGA CTG CCA ATG TTC TG</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Recombinant DNA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">For complete list of recombinant DNA, please
refer to <xref ref-type="supplementary-material" rid="SD5">Table
S5</xref>.</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">pcDNA3.1(−)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Thermofisher</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: solid 1px" valign="top">Cat#
V79520</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="border-bottom: solid 1px" valign="top">Software and Algorithms</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ImageJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MiniAnalysis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.synaptosoft.com/MiniAnalysis/">http://www.synaptosoft.com/MiniAnalysis/</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v6.0.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GraphPad Prism</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v7.01</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MATLAB</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com/products/matlab.html">https://www.mathworks.com/products/matlab.html</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v8.6.0.267246</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Clampex and Multiclamp</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com/products/axon-patch-clamp-system/acquisition-and-analysis-software/pclamp-software-suite">https://www.moleculardevices.com/products/axon-patch-clamp-system/acquisition-and-analysis-software/pclamp-software-suite</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v10.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ANY-maze</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.stoeltingco.com/any-maze-video-tracking-software-1224.html">https://www.stoeltingco.com/any-maze-video-tracking-software-1224.html</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Imaris</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/downloads">https://imaris.oxinst.com/downloads</ext-link>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">v9.2.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Single-cell RNA-seq code availability</td>
<td align="left" colspan="1" rowspan="1" valign="top">This Paper</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://github.com/aseveritt/Darbandi_TBR1_L5scRNAseq">https://github.com/aseveritt/Darbandi_TBR1_L5scRNAseq</ext-link>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<boxed-text id="BX1" orientation="portrait" position="float">
<caption>
<title>Highlights</title>
</caption>
<list id="L2" list-type="bullet">
<list-item>
<p id="P140"><italic>Tbr1</italic> promotes and maintains spine maturation and
synaptogenesis through WNT signaling</p>
</list-item>
<list-item>
<p id="P141">Promoting WNT signaling rescues dendritic spine and synaptic
defects in <italic>Tbr1</italic> mutants</p>
</list-item>
<list-item>
<p id="P142">TBR1 directly regulates transcriptional circuits that control
ASD-risk genes</p>
</list-item>
</list>
</boxed-text>
</floats-group>
</article>
</pmc-articleset>